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Abstract 
 55 
Purpose: The purpose of this educational report is to provide an overview of the 
present state-of-the-art PET auto-segmentation (PET-AS) algorithms and their respective 
validation, with an emphasis on providing the user with help in understanding the challenges 
and pitfalls associated with selecting and implementing a PET-AS algorithm for a particular 
application.  60 
Approach: A brief description of the different types of PET-AS algorithms is provided 
using a classification based on method complexity and type. The advantages and the 
limitations of the current PET-AS algorithms are highlighted based on current publications 
and existing comparison studies. A review of the available image datasets and contour 
evaluation metrics in terms of their applicability for establishing a standardized evaluation of 65 
PET-AS algorithms is provided. The performance requirements for the algorithms and their 
dependence on the application, the radiotracer used and the evaluation criteria are described 
and discussed. Finally, a procedure for algorithm acceptance and implementation, as well as 
the complementary role of manual and auto-segmentation are addressed. 
Findings: A large number of PET-AS algorithms have been developed within the last 70 
20 years. Many of the proposed algorithms are based on either fixed or adaptively selected 
thresholds. More recently, numerous papers have proposed the use of more advanced 
image analysis paradigms to perform semi-automated delineation of the PET images. 
However, the level of algorithm validation is variable and for most published algorithms is 
either insufficient or inconsistent which prevents recommending a single algorithm. This is 75 
compounded by the fact that realistic image configurations with low signal-to-noise ratios 
(SNR) and heterogeneous tracer distributions have rarely been used. Large variations in the 
evaluation methods used in the literature point to the need for a standardized evaluation 
protocol.   
Conclusions: Available comparison studies suggest that PET-AS algorithms relying on 80 
advanced image paradigms provide generally more accurate segmentation than approaches 
based on PET activity thresholds, particularly for realistic configurations. However, this may 
not be the case for simple shape lesions in situations with a narrower range of parameters, 
where simpler methods may also perform well. Recent algorithms which employ some type 
of consensus or automatic selection between several PET-AS methods have potential to 85 
overcome the limitations of the individual methods when appropriately trained. In either case, 
accuracy evaluation is required for each different PET scanner and scanning and image 
reconstruction protocol. For the simpler, less robust approaches, adaptation to scanning 
conditions, tumor type and tumor location by optimization of parameters is necessary. The 
results from the method evaluation stage can be used to estimate the contouring uncertainty. 90 
All PET-AS contours should be critically verified by a physician.  A standard test, i.e., a 
benchmark dedicated to evaluating both existing and future PET-AS algorithms needs to be 
designed, in order to aid clinicians in evaluating and selecting PET-AS algorithms and to 
establish performance limits for their acceptance for clinical use. The initial steps towards 
designing and building such a standard are undertaken by the task group members.  95 
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I. INTRODUCTION  
 
Positron emission tomography (PET) has the potential to improve the outcome of cancer 145 
therapy because it allows the identification and characterization of tumors to be conducted 
based on their metabolic properties1, which are inherently tied to cancer biology. PET is 
helpful in delineating the tumor target for radiation therapy, in quantifying tumor burden for 
therapy assessment, in determining patient prognosis and in detecting and quantifying 
recurrent or metastatic disease. This is especially true when the cancer lesion boundaries 150 
are not easily distinguished from surrounding normal tissue in anatomical images. Combined 
PET/CT (computed tomography) provides both anatomical/morphological and functional 
information in one imaging session. In addition to segmentation, this allows for the division of 
the tumors into subregions based on metabolic activity, which could potentially be used to 
treat/evaluate these subregions differentially (e.g., by increasing the dose to the more 155 
aggressive and radioresistant sub-volumes, an approach known as “dose painting”2). 
Accurate delineation of the metabolic tumor volume in PET is important for predicting and 
monitoring response to therapy. Apart from standardized uptake value (SUV) measurements, 
3,4
 other parameters (e.g., total lesion glycolysis (TLG) or textural and shape features,  as 
well as tracer kinetic parameters) with complementary/additional predictive/prognostic value 160 
can be extracted from PET images. 
For radiation therapy, leaving parts of the tumor untreated, because its extent is 
underestimated by anatomic imaging, or conversely irradiating healthy tissue because 
boundaries between the tumor and the adjacent normal tissue cannot be defined, can result 
in suboptimal response and/or (possibly severe) adverse side-effects. It has been shown in 165 
several clinical studies that PET, using the [18F]2-fluoro-2-deoxy-D-glucose  
(Fluorodeoxyglucose) radiotracer (18F-FDG PET), has led to changes in clinical management 
for about 30% of patients5-7. Other studies, involving non-small-cell lung cancer (NSCLC)8, 9, 
10
  and head and neck (H&N) cancer11 have demonstrated that the incorporation of PET 
imaging in radiotherapy planning can result in significant changes (either increase or 170 
decrease) in treatment volumes.  
In addition, the quantitative assessment of the metabolically active tumor volume, may 
provide independent prognostic or predictive information. This has been shown in several 
malignancies, including locally advanced esophageal cancer12, non-Hodgkin lymphoma13, 
pleural mesothelioma14, cervical and H&N cancers15  and lung cancer16.  175 
These promising data impose the need to establish and validate algorithms for the 
segmentation of PET metabolic volumes before and during treatment. The gross tumor 
volumes (GTV) defined by PET are intended to contain the macroscopic extend of the 
tumors. Currently, inaccuracies in defining PET-based GTV arise from variations in the 
biological processes determining the radiotracer uptake, as well as from physical and image 180 
acquisition phenomena  which affect the reconstructed PET images4, 17-22. Furthermore, 
uncertainty can be introduced by the segmentation process itself. It has been shown that 
volume differences of up to 200% can arise from using different GTV contouring algorithms23.  
Regardless of these uncertainties, many radiation oncology departments have started 
using PET/CT for lesion delineation in radiation treatment planning (RTP)1, 7-9, 11,24. Numerical 185 
auto-segmentation techniques can be used for guidance in the delineation process, have 
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been shown to reduce intra- and inter-observer variations25, 26 and some commercial vendors 
are now offering tools for semi-automatic delineation of tumor volumes in PET images for 
radiotherapy planning or response assessment. While these approaches may work 
reasonably well when applied in conjunction with anatomical imaging and clinical expertise, 190 
their accuracy and limitations have not been fully assessed.  
Due to the complexity of the problem of PET based tumor segmentation and due to the 
abundance of potentially applicable numerical approaches, a large variety of automatic, 
semiautomatic and combined PET-AS approaches have been proposed over the past 20 
years27-30 Multiple semi-automatic approaches derived from phantom data as well as fully 195 
automated algorithms differing in terms of the algorithmic basis, fundamental assumptions, 
clinical goals, workflow, and accuracy have been proposed. In addition, algorithms for 
segmenting combinations of images from PET and other imaging modalities have appeared 
in literature31-34. The majority of these approaches have been tested on either simplistic 
phantom studies or patient datasets where the ground truth is largely unknown. Finally, only 200 
a few of these algorithms have been tested for their ability to segment lesions with irregular 
shapes or non-uniform activity distributions, which are essential for the implementation of 
accurate delineation protocols. In addition, most methods have been evaluated using 
different datasets and protocols, which makes comparing the results difficult, even 
impossible. As a result, in essence, there is currently no commonly adopted technique for 205 
reliable, routine, clinical PET image auto-segmentation.  
In this educational report we provide a description with examples of the main classes of 
PET-AS algorithms (section II), highlight the advantages and the limitations of the current 
techniques (section III) and discuss possible evaluation approaches (section IV). In that 
section the types of available image datasets and the existing approaches for contour 210 
evaluation are discussed with the intention of laying out a basis for a standard for effective 
evaluation of PET auto-segmentation algorithms. The clinician interested in the practical 
aspects of PET segmentation may find most useful section V, which highlights the biological, 
physiological and image acquisition factors affecting the performance of the PET-AS 
methods, as well as preliminary guidelines for their acceptance and implementation. 215 
  
This	article	is	protected	by	copyright.	All	rights	reserved
Au
th
or
 M
an
us
cr
ip
t
 7 
 
 
II. DESCRIPTION AND CLASSIFICATION OF THE ALGORITHMS 
 
The following is a glossary of the abbreviation, definitions and notations used in this 220 
report: 
Abbreviations: 
ARG – Adaptive Region Growing 
ATS – Adaptive Threshold Segmentation 
BTV – Biological Target Volume 225 
CT – Computed Tomography 
CTV – Clinical Target Volume 
DSC - Dice Similarity Coefficient 
DWT- discrete wavelet transforms  
FTS – Fixed Threshold Segmentation 230 
EM – Expectation Maximization 
FCM - Fuzzy C-Means 
FDG – [18F]2-fluoro-2-deoxy-D-glucose  (Fluorodeoxyglucose) 
FLT – 18F-3′-fluoro-3′-deoxy- L-thymidine 
F-MISO – 18F-fluoromisonidazole  235 
FOM – Figure of Merit 
GTV – Gross Tumor Volume 
H&N – Head and Neck 
ML - Maximum Likelihood 
MRI – Magnetic Resonance Imaging 240 
MVLS – Multi Valued Level Sets 
NEMA - National Electrical Manufacturers Association 
NGTDM - neighborhood gray-tone difference matrices  
NSCLC – Non-Small Cell Lung Cancer 
PET – Positron Emission Tomography 245 
PET-AS – PET Auto - Segmentation  
PPV - Positive Predictive Value 
PSF – Point Spread Function 
PTV - Planning Target Volume 
PVE – Partial Volume Effect 250 
ROC - Receiver Operating Characteristic 
SNR – Signal to Noise Ratio 
 
Definitions: 
ROI (Region of Interest): A 2D or 3D region drawn on an image for purposes of restricting 255 
and focusing analysis to its contents. It is closely related to and often used interchangeably 
with volume of interest (VOI). 
SUV (Standardized Uptake Value): A measure of the intensity of radiotracer uptake in an 
object (lesion or body region) or region of interest; measured activity in that region is 
normalized to the injected activity and some measurement of patient size, most commonly 260 
weight (mass).  
TLG (Total Lesion Glycolysis):  The integral of the FDG-SUV over the volume, also equal to 
the product of the mean FDG-SUV and the volume. The same paradigm can be applied to 
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other radiotracers and is called for instance Total Proliferative Volume, or Total Hypoxic 
Volume in the case of FLT or FMISO, respectively. 265 
VOI (Volume of Interest): A 3D region defined in a set of images for purposes of restricting 
and focusing analysis to its contents. It is closely related to and often used interchangeably 
with region of interest (ROI). 
 
Notation: 270 ܫ: The image set. ܫ�ை�: The VOI in image set ܫ that the segmented region is taken from. I⏞: The segmented region from image set ܫ.
 ܫ௜: The intensity of the �th element (image pixel) from image set ܫ. This element is commonly 
normalized with respect to activity and weight to SUV but can be further normalized. 275 �௜: Normalized uptake for the �th voxel (see Appendix II). ܶ(Threshold): Commonly used in threshold segmentation. It defines the value at which a 
voxel is segregated between one set and another. ܶ∗ (Threshold): The estimated segmentation threshold. �ሺܶሻ: Volume as a function of threshold. 280 �௞௡௢௪௡: The known volume of a segmented object. �௜:  The position of the �th voxel. ܿ௞௡: The cluster center of the ݇th cluster at the �th iteration. �௜௞௡ : The membership probability of the �th pixel in the ݇th cluster at the �th iteration. � : The number of images sets/modalities. 285 ܿ௜+/−: The internal/external (+/-) mean intensities of the enclosed contour region at level set 
= 0 in the �th image set. λi+/-: User defined importance weights for inclusion/exclusion (+/-) from a region defined by 
the enclosed contour at level set in the �th image set. � : A level set function. 290 Ω: The domain of the image. 
II.A. Possible classifications  
 The first objective of this document is to provide introductory information about the 
different classes of PET auto-segmentation (PET-AS) algorithms. Classifications of PET-AS 
algorithms can be based on several different aspects: 295 
1. The segmentation/image processing algorithm employed and its assumptions and 
complexity; 
2. The use of pre- and post- processing steps; 
3. The level of automation; 
 The first classification, relying on the type of image segmentation paradigm (e.g., 300 
simple or adaptive thresholding, active contours, statistical image segmentation, clustering, 
etc.), has been used in previous reviews27, 29, 35, 36. In most cases, detailed descriptions of the 
numerical algorithms and their assumptions and limitations are given.  
 The second classification is based on the use of pre- and post- processing steps. Most 
algorithms do not use pre-processing steps, although some use either denoising or 305 
deconvolution image restoration techniques before the segmentation or as part of the 
algorithm itself37, 38. Other algorithms require either an image-based database28, 39, 40 to build 
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a classifier (i.e. learning algorithms), or phantom acquisitions for the optimization of 
parameters (i.e. adaptive threshold algorithms). 
 Regarding the third classification based on automation, Udupa, et al.41 divide image 310 
segmentation into two processes: recognition and delineation, and point to the “essential” 
need of “incorporation of high level expert knowledge into the computer algorithm, especially 
for the recognition step.” For this reason, most existing algorithms rely on the identification of 
the tumor first, by the user drawing a volume of interest (VOI) around the tumor to delineate 
(denoted from here onwards as “standard user interaction”, see Table 1), whereas other 315 
approaches require the identification of the tumor after the segmentation process in the 
resulting map (e.g., Belhassen, et al.28). Other examples of manual interaction are user-
definition of background regions (used by some of the adaptive threshold algorithms), 
manual selection of markers to initialize the algorithm 42, or the manual input of parameters in 
case of failure of the automatic initialization43. Furthermore, the level of automation can be 320 
quite difficult to assess, as factors such as the requirement of building a classifier for each 
image region, the individual optimization for each combination of scanner 
system/reconstruction algorithm, the selection and validation of the parameters of the 
optimization approach, or finally, the detection of lesions to segment, are usually not included 
in these assessments. In practice, all algorithms require some level of user interaction. 325 
 In the following section we used the first classification scheme with emphasis on the 
algorithm complexity.  
II.B. Classes of algorithms for PET auto-segmentation 
II.B.1 Fixed and Adaptive Threshold algorithms  
Segmentation via a threshold is conceptually very simple. It consists of defining a 330 
specific uptake (often expressed as a fixed fraction or percentage of SUV) between the 
background and imaged object’s intensities (tracer uptake) and then using that intensity to 
partition the image and recover the true object’s boundaries. All voxels with intensities at or 
above the threshold are assigned to one set while the remaining voxels are assigned the 
other (Appendix I). The details of how the threshold and the uptake values are normalized 335 
are discussed in Appendix II. 
The decision to use threshold segmentation is generally based upon its simplicity and 
the ease of implementation. Threshold segmentation carries a number of implied 
assumptions that should be understood and accounted for. These are:  The true object has a well-defined boundary and uniform uptake near its boundary, 340 
i.e., the image is bi-modal.  The background intensity is uniform around the object.  The noise in the background and in the object is small compared to the intensity 
change at the tumor edge.  The resolution is constant near the edges of the object. 345  The model, used to define the threshold, is consistent with its application, e.g., a 
segmentation scheme designed for measuring tumor volume may not be appropriate 
for radiation therapy and vice versa (see section V.A).  
In practice, these assumptions rarely hold and some effort is required to determine their 
validity/acceptability in the context of the intended application.   350 
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Several points above are illustrated in a review of PET segmentation by Lee29. In this 
review, the effect of the thickness of the phantom wall on estimating the segmentation 
threshold and the dependence of this effect on the Point Spread Function (PSF) of the PET 
scanner, were shown via mathematical analysis. This work also showed that to obtain the 355 
correct threshold on a phantom with cold walls (a certain thickness of material without any 
uptake, such as the plastic surrounding spheres in physical phantoms), a lower threshold is 
required than for the case without walls, and that due to the limited PET spatial resolution, 
small volumes require larger thresholds. This was further investigated recently, 
demonstrating the important impact of cold walls on the segmentation approaches, and the 360 
potential improvement brought by thin-wall inserts 44 45. A similar result was shown by Biehl, 
et al 46, who concluded that for NSCLC the optimal threshold for their specific scanner and 
protocol was related to volume as shown in Appendix I. Finally, it is interesting to note that, 
given knowledge of the local PSF and the assumption of uniform uptake, the threshold for the 
lesion’s boundary can be estimated analytically, with the result being independent from the 365 
tumor to background ratio, provided the background has been subtracted beforehand47. 
Generally, threshold segmentation can be loosely categorized into two separate 
categories: fixed threshold segmentation (FTS) and adaptive threshold segmentation (ATS). 
In FTS a general test/model of the problem is developed and a set of parameters is 
estimated by minimizing the error of the model in order to deduce an “optimal” threshold, ܶ∗. 370 
The threshold value may be dependent or not (e.g. 42% of peak lesion activity48  or 
SUV=2.549) on the tumor to background ratios. Other tumor or image aspects are generally 
ignored. For ATS, an objective function is chosen that generates a threshold based upon the 
properties of each individual tumor/object and PET image. In this case, rather than 
depending on simple measures, such as tumor to background ratio, the threshold calculation 375 
depends upon an ensemble of lesion properties such as volume 46 48, 50-52 or SUV mean-
value53, and thus makes the threshold segmentation process iterative. 
Both FTS and ATS have been discussed in several recent literature reviews of general 
segmentation in PET29, 36, 39, 54  Each of these reviews provides a fairly complete literature 
survey of the state of various threshold segmentation algorithms. In addition, the review by 380 
Zaidi and El Naqa54 provides a brief description and summary of the rationale of many ATS 
algorithms. These are summarized in Table A1 of Appendix I.  
 
II.B.2. Advanced algorithms 
A list of some of the advanced PET-AS algorithms published is given in Table 1, with 385 
a focus on the evaluation protocols that were followed. Below they are divided into three 
subcategories (advanced algorithms applied directly to PET images, approaches combined 
with image processing or reconstruction, and those dealing with multiple imaging modalities), 
which are discussed in separate subsections B.2 to B.4. 
II.B.2. a) Gradient-based segmentation 390 
The underlying assumption in threshold-based delineation (II.B.1) is that the uptake 
within the target is significantly different from that in the background. With this idea in mind, 
the gradient naturally finds the transition contour that delineates a high-uptake volume from 
the surrounding low uptake regions. The immediate advantage of this alternative method is 
that uptake inside and outside the target need not be uniform for successful segmentation, 395 
nor need it be constant along the contour. 
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In practice, the method consists of computing the gradient vector for each voxel and 
then using it to form a new image composed of the gradient magnitude values. Segmentation 
based on gradient information is an important part of what the human visual system does 
when looking at natural scenes. The difficulty lies in interpreting the gradient image in order 400 
to translate the relevant information into target contours. The general idea is to locate and 
follow the crests of the gradient magnitude. The points where the gradient is the largest in 
magnitude (where the second derivative, or Laplacian, is null) correspond to the target 
contours. There are several ways to locate the crests. For instance, adaptive contours or 
“snakes“ with various smoothness constraints can be programmed in such a way that the 405 
contours are attracted towards the crest.55 Another very popular way to track the gradient 
crests is the watershed transform. It considers the gradient image as a landscape in which 
the gradient crests are mountain chains. Then it “floods” the landscape and keeps a record of 
the boundaries of all hydrographic basins that progressively merge as the water level rises. 
The hierarchy of all basins can be displayed as a tree in a dendrogram. Clustering tools can 410 
help in identifying the branch that gathers all basins corresponding to the target. 
The quality of gradient-based segmentation depends on the accuracy and precision of 
the gradient information, which can be biased by spatial resolution blur. For objects with a 
concave or convex surface, the uptake spill-in and spill-out caused by blur tends to slightly 
shift, smooth, and distort the real object boundary. This effect can be partially compensated 415 
for with deblurring methods, such as deconvolution algorithms and some tools for Partial 
Volume Effect (PVE) correction. The gradient computation also amplifies the image noise. 
Therefore, denoising tools are needed as well, provided they do not decrease the image 
resolution. 
The algorithm described by Geets, et al.37 relies on deblurring and denoising tools prior 420 
to segmentation. The deblurring parameters are adjusted according to the resolution of the 
PET system and are therefore PET-camera dependent. The watershed transform is applied 
to the gradient magnitude image and a clustering technique creates a hierarchy of basins. 
The user can choose the tree branch associated with the high-uptake region in the images 
expected to correspond to the target volume. In the case of a low signal-to-background ratio 425 
(surrounding inflammation, other causes of tracer concentration, uptake reduction due to 
treatment), the hierarchy can get more complicated and the branch corresponding to the 
target volume might be difficult to isolate. This usually indicates that the images do not 
convey enough information for the target volume to be accurately delineated. This approach 
has been validated using phantom PET acquisitions as well as clinical datasets of both 430 
H&N37 and lung56 tumors with tri-dimensional (3D) histopathology reconstructions as ground 
truths.  
II.B.2. b) Region growing and adaptive region growing   
Region growing algorithms start from a seed region inside the object and progressively 
include the neighboring voxels to the region if they satisfy certain similarity criteria57-59. 435 
Similarity is often calculated based on image intensity, but can be based on other features 
such as textures. Let I(x) represent the image intensity at x. The similarity criteria can be a 
fixed interval: I(x)  [lower, upper], or a confidence interval: I(x)  [m - f, m + f], where m 
and  are the mean intensity and standard deviation of the current region, and f is a factor 
defined by the user59. Region growing with a fixed interval is essentially a connected 440 
threshold algorithm. Small f restricts the inclusion of voxels to only those having very similar 
intensities to the mean in the current region, and thus can result in under growth. Large f 
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relaxes the similarity criteria, and thus may result in over growth into neighboring regions. It is 
often difficult, if not impossible to identify experimentally an optimal f for all objects. For 
example, four different f values were experimentally determined based on the maximum 445 
intensity and its location using phantoms by Day, et al.60. The authors noted that these f 
values are specific to their clinic.  
To overcome this limitation, an adaptive region growing (ARG) algorithm that can 
automatically identify f for each specific object in PET was proposed by Li, et al.55. As 
illustrated in Fig. 1, in ARG f is varied from small to large values so that the grown volume 450 
changes from the small seed region to the entire image. A sharp volume increase occurs at a 
certain f* where the region grows just beyond the object (hot phantom or tumor) into the 
background (warm water or normal tissue). Because the background typically consists of 
large homogeneous regions, a great number of voxels are added to the current region at this 
transition point. The ARG algorithm automatically identifies f* for which the volume would be 455 
increased by more than 200% at the next iterative value of f. The resulting volume V* was 
proven to be quite an accurate representation of the homogeneous object. The quality of the 
segmentation performed by ARG depends mainly on the homogeneity of the background and 
the contrast between the tumor and background. The performance of ARG in segmenting 
tumors with various levels of heterogeneous uptake still needs to be studied. The ARG 460 
algorithm does not have any parameters that require experimental determination. It uses the 
intrinsic contrast between a tumor and its neighboring normal tissue in each image to 
determine the tumor boundary. Therefore, it can be directly applied to various imaging 
conditions such as different scanners or imaging protocols. 
 465 
 
           (a)          (b)             
   
        (c)           (d) 
Fig.1. An illustration of applying the adaptive region growing (ARG) algorithm to PET: (a) plot 470 
of segmented volume growing as a function of f, the arrow indicates the location of the 
transition point f* for a spherical lesion in a PET/CT of a phantom (b): the thin blue contour 
indicates the delineated volume V*. (c) - (d) selection of f* and results for an esophageal 
tumor. 
f* 
f* 
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Another approach based on adaptive region growing has been recently proposed by 475 
Hofheinz, et al.61, in which the approach was made able to deal with heterogeneous 
distributions. The method is based on an adaptive threshold, in which instead of a lesion-
specific threshold for the whole ROI, a voxel-specific threshold is computed locally in the 
close vicinity of the voxel. The absolute threshold Tabs for the considered voxel is then 
obtained based on a parameter T previously determined with phantom measurements 480 
(T=0.39): Tabs=T×(R-Bg)+Bg, where R is a tumour reference value (e.g., ROI maximum) and 
Bg is the background. Region growing algorithms use statistical properties (mean and 
standard deviation) of the region to stop the iterative process60. The algorithms, which exploit 
the statistical properties of a noisy function and a noisy argument and rely on probabilistic 
calculations, are described in the next subsection.  485 
 Table 1. Summary of the main characteristics of some representative advanced PET-AS 
algorithms (not an exhaustive list) and their respective evaluation. 
Reference(s) 
Image 
segmentation 
paradigm(s) used 
User 
interaction 1 
Pre- and post-
processing steps 
Aimed 
application2 
Validation data 
and ground truth 
3
 
Accuracy 
evaluation 
on realistic 
tumors5 
Robustness 
evaluation6 
Repeatability 
evaluation 
Tylski, et al. 
2006 62  Watershed 
Std + multiple 
markers 
placement 
None Global PA(1): Vol. and CiTu images No No No 
Werner-
Wasik, et al. 
2012 63 
Gradient-based 
Std  + 
initialization 
using drawn 
diameters 
Unknown Global PA(5): Diam. 31 MCST: Vol. Yes Yes Yes 
Geets, et al. 
200737 Gradient-based 
Std  + 
initialization 
Denoising and 
deconvolution 
steps 
Global 
PS(1) and PA(1): 
Vol. + Diam. 
7 CiTuH: 
Complete 
No No No 
El Naqa, et al. 
200864 
 
AT + active 
contours 
Std + several 
parameters to 
set 
None Global PA(1): Vol. 1 CiTu - Ø Yes No Yes 
El Naqa, et al. 
200731 
Multi-modal 
(PET/CT) active 
contours 
Std  + 
initialization of 
the contour 
shape, selection 
of weights 
Normalization and 
registering of PET 
and CT images, 
deconvolution of 
PET images. 
GTV definition 
on  PET/CT 
PA(1): Vol. 
2 CiTu: MC(1), FT Yes No No 
Dewalle-
Vignion, et al. 
201165 
Possibility theory 
applied to MIP 
projections 
Std  None  Global 
PA(1): Vol. 
5 MCST: Vox. 
7 CiTuH: 
Complete 
Yes No No 
Belhassen 
and Zaidi 
201028 
Improved Fuzzy C-
Means (FCM) 
A posteriori 
interpretation of 
resulting classes 
in the 
segmentation of 
entire image 
Denoising, wavelet 
decompositions Global 
3 AST: Vox. 
21 CiTuH: Diam. 
7 CiTuH: 
Complete 
Yes No No 
Aristophanous
, et al. 200766 
Gaussian mixture 
modeling without 
spatial constraints 
Std  + 
initialization of 
the model and 
selection of the 
number of 
classes 
None Pulmonary tumors 7 CiTu: Ø No No Yes 
Montgomery, 
et al. 200767 
Multi scale Markov 
field segmentation 
A posteriori 
interpretation of 
resulting 
segmentation on 
the entire image 
Wavelet 
decompositions Global 
PA(1) : Vol. 
3 CiTu: Ø No No No 
Hatt, et al. 
200768 
Fuzzy Hidden 
Markov Chains Std  None Global 
PS(1) and PA(2): 
Vox. No No No 
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Hatt, et al. 
200969, 2010 
70
,201143 
Fuzzy locally 
adaptive Bayesian Std None Global 
PS(1) and PA(4): 
Vox. 
20 MCST: Vox. 
18 CiTuH: Diam. 
 Yes Yes Yes 
Day, et al. 
200960 
Region growing 
based on mean 
and SD of the 
region 
Std + 
optimization on 
each scanner 
None  Rectal tumors 18 CiTu: MC(1) No No No 
Yu, et al. 
200940, 
Markel, et al. 
201371 
Decision tree built 
based on learning 
of PET and CT 
textural features 
A posteriori 
interpretation of 
resulting 
segmentation on 
the entire image 
Learning for 
building  the 
decision tree 
GTV definition 
of H&N and 
lung tumors 
10 CiTu: MC(3) 
31 CiTu: MC(3) No No No 
Sharif, et al. 
201072, 201273 Neural network 
A posteriori 
interpretation of 
resulting 
segmentation on 
the entire image. 
Learning for 
building the neural 
network 
Global 
PA(1): Vol. 
3 AST: Vox. 
1 CiTuH: Diam. 
No No Yes 
Sebastian, et 
al. 200674 
Spherical Mean 
shift Std  
Resampling in a 
different spatial 
domain 
Global 280 AST: Vox. No No No 
Janssen, et 
al. 200975 
Voxels 
classification based 
on time-activity 
curve 
Std  + 
Initialization and 
choice of the 
number of 
classes 
Only on dynamic 
imaging, denoising 
and deconvolution 
steps 
Rectal tumors 
in dynamic 
imaging 
PA(1): Vol. + 
Diam. 
21 CiTu: MC(1) 
No No No 
De Bernardi, 
et al. 201076 
Combined with 
PVE (image 
reconstruction) 
Std + 
initialization 
PSF model of the 
scanner and 
access to raw data  
required 
Global PA(1): Vol. No Yes No 
Bagci, et al. 
201333 
Multimodal random 
walk Std 
Multimodal images 
registration 
Global for 
PET/CT or 
PET/MR 
77 CiTu: MC(3) 
PA(1) Yes No No 
Onoma, et al. 
2014 77 
Improved random 
walk Std None Global PA(1), 4 AST: 
Vox, 14 CiTu: 
MC(2) 
Yes No No 
Song, et al. 
201332 
Markov field + 
graph cut Std None Global 3 CiTu: MC(3) Yes No No 
Hofheinz, et 
al. 201361 
Locally adaptive 
thresholding 
Std + one 
parameter to 
determine on 
phantom 
acquisitions 
None Global 30 AST: Vox. Yes No No 
Abdoli, et al. 
201378 Active contour 
Std + several 
parameters to 
optimize 
Wavelet 
decompositions Global 
1 AST: Vox. 
9 CiTuH: 
Complete. 
3 CiTuH: 
Complete 
2 CiTuH: 
Complete 
No Yes No 
Mu, et al. 
2015 79 
Level set combined 
with PET/CT Fuzzy 
C-Means 
Std None Specific to 
cervix 
7 AST: Vox, 27 
CiTu: MC(2) Yes No No 
Cui, et al. 
2015 80 
Graph cut 
improved with 
topology modeling 
Std + one free 
parameter 
previously 
optimized 
PET/CT 
registration 
Specific to lung 
tumors and 
PET/CT 
20 PA(1), 40 
CiTu(2) Yes No No 
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Lapuyade-
Lahorgue, et 
al. 2015 81 
Generalized fuzzy 
C-means with 
automated norm 
estimation 
Std None Global 
PA(4): Vol. 
34 MCST: Vox. 
9 CiTu: MC(3). Yes Yes Yes 
Devic et al, 
2016 82  
Differential uptake 
volume histograms 
for identifying 
biological target 
sub-volumes 
Selection of 
three ROIs 
encompassing  
PET avid area; 
iterative 
decomposition 
of differential 
uptake 
histograms into 
multiple 
Gaussian 
functions 
None 
Isolation of 
glucose 
phenotype 
driven 
biological sub-
volumes 
specific to 
NSCLC,  
None No No No 
Berthon et al, 
2016 83 
Decision tree 
based learning 
using nine different 
segmentation 
approaches (region 
growing, 
thresholds, FCM, 
etc.) with the goal 
of selecting the 
most appropriate 
method given the 
image 
characteristics 
Std 
Learning on 100 
simulated cases to 
train/build the 
decision tree 
Global 85 NSTuP: Vox. 
 
Yes No No 
Schaefer et 
al, 2016 84 
Consensus 
between contours 
from 3 
segmentation 
methods (contrast-
oriented, possibility 
theory, adaptive 
thresholding) 
based on majority 
vote or  STAPLE 
Std None Global 
22 CiTuH; 
Complete 
10 CiTu: MC(4) 
10 CiTu: MC(1) 
Yes No Yes 
 
Table legend 
1
 std = « standard » interaction (i.e. the metabolic volume of interest is first manually isolated in a 490 
region of interest that is used as an input to the algorithm.) 
2
 global = not application specific 
3
 PA(x) = Phantom (spheres) Acquisitions on x different scanners; PS(x) = Phantom (spheres) 
Simulations on x different scanners; AST = Analytically Simulated Tumors; MCST = Monte Carlo 
Simulated Tumors; NSTuP = Non spherical tumors simulated in phantoms (thin-wall inserts, printed 495 
phantoms, etc.). CiTu = Clinical Tumors; CiTuH = Clinical Tumors with Histopathology 
Vol. = only volume; Vox. = voxel-by-voxel; Diam = histopathology maximum diameter; Complete = 3D 
histopathology reconstruction; MC(x) = manual contouring by x experts; FT = fixed threshold, AT = 
adaptive threshold 
4
 Highly heterogeneous, complex shapes, low contrasts and rigorous ground truth. 500 
5
 Requires multiple acquisitions on different systems and a large number of parameters. 
6 With respect to different scanners and protocols 
 II.B.2. c) Statistical  
Statistical image segmentation 
Statistical image segmentation aims at classifying pixels/voxels and creating regions in 505 
an image or volume based on the statistical properties of these regions and voxels, by relying 
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on probabilistic calculations and estimation for the decision process. Numerous approaches 
have been proposed; most are based on Bayesian inference. In essence, it is assumed that 
the observed image Y (usually taking its values in the set of real numbers) is a noisy and 
degraded version of a ground truth field X (usually taking its values in several classes C). 510 
Therefore, X has to be estimated from Y, assuming that X and Y can be modeled as 
realizations of random variables. These algorithms usually combine an iterative estimation 
procedure of the parameters of interest, since parameters defining the distributions of X and 
Y are not known in real situations. In addition, a decision step to classify voxels (i.e. 
assigning a label among the possible values of X to each voxel, based on its observation Y) 515 
and the estimated distributions of X and Y, are required. Hence, the voxel classification is 
carried out based on the previously estimated statistical properties and the resulting 
probabilities for each voxel to belong to a specific class or region. 
 
Spatial and observation models 520 
The parameters of interest are usually defined within both a spatial model of X (also 
called a priori model) and an observation model of Y (also called a noise model). Most spatial 
models are based on Markovian modeling of the voxels field, such as Markov chains, fields, 
or trees, although simpler spatial neighboring definitions (blind, adaptive or contextual) also 
exist85. Noise models are used to model uncertainty in the decision to classify a given voxel, 525 
and are most often defined using Gaussian distributions, but more advanced noise models 
have also been proposed, allowing for the modeling of correlated, multi-dimensional and non-
Gaussian noise distributions86. Parameters estimation is usually carried out using algorithms 
such as Expectation Maximization (EM), Stochastic EM (SEM) or Iterative Conditional 
Estimation (ICE), depending on the assumptions of the model. These methods have been 530 
demonstrated to provide robust segmentation results in several imaging applications, such as 
astronomical, satellite or radar images, by selecting appropriate noise models. 
 
Adaptation to PET image segmentation 
Some of the algorithms above, have been applied to PET image segmentation. One 535 
example is the use of a multi-resolution model applied to wavelet decomposition of the PET 
images within a Markov field framework67. Another approach is a mixture of Gaussian 
distributions for classification without spatial modeling66. Although these models are robust 
for noisy distributions of voxels (each voxel has an assigned label, but its observation is 
noisy), they do not explicitly take into account imprecision of the acquired data (a given voxel 540 
can contain a mixture of different classes). Therefore, they do not include the modeling of the 
fuzzy nature of PET images. As a result, to be applied efficiently to PET images, which are 
not only intrinsically noisy but also blurry due to Partial Volume Effect (PVE), more recent 
models can be used that allow the modeling of the imprecision within the statistical 
framework, using a combination of “hard” classes and a fuzzy measure. In such a model, the 545 
actual image, X does not take its values in a set number of classes, but in a continuous [0,1] 
interval: the fuzzy Lebesgue measure being associated with the open interval (0,1) and the 
Dirac measure being associated with {0} and {1}87. Such a model has been proposed using 
Markov chains88 and fields85 and also using local neighborhoods without Markovian 
modeling. These models retain the flexibility and robustness of statistical and Bayesian 550 
algorithms versus noise, with the added ability to deal with more complex distributions, due to 
the presence of both hard and fuzzy classes in the images. The Fuzzy Locally Adaptive 
Bayesian (FLAB) method takes advantage of this model69, which had previously been 
proposed within the context of Markov chains68. In addition, FLAB modeling has been 
extended to take into account heterogeneous uptake distributions by considering three 555 
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classes and their associated fuzzy transitions instead of only two classes and one fuzzy 
transition. The extended FLAB model has been validated on phantom acquisitions and 
simulated tumors, as well as clinical datasets70. 
II.B.2. d) Learning and texture-based segmentation algorithms  
For PET image segmentation, the learning task consists of discriminating tracer uptake 560 
in lesion voxels (foreground) from surrounding normal tissue voxels (background) based on a 
set of extracted features from these images28. Two common categories of statistical learning 
approaches have been proposed: supervised and unsupervised89, 90. Supervised learning is 
used to estimate an unknown (input, output) mapping from known (labeled) samples called 
the training set (e.g., classification of lesions given a database of example images). In 565 
unsupervised learning, only input samples are given to the learning system without their 
labels (e.g., clustering or dimensionality reduction). 
In machine learning and classification there are two steps: training and testing. In the 
training step, the optimal parameters of the model are determined given the training data and 
its best in-sample performance is assessed. This is usually followed by a validation step, 570 
aimed at optimal model selection. The testing step then specifically aims to estimate the 
expected (out-of-sample) performance of a model with respect to its chosen training 
parameters. A recent example of such a development is the ATLAAS method 83, which is an 
automatic decision tree that selects the most appropriate PET-AS method based on several 
image characteristics, achieving significantly better accuracy than any of the PET-AS 575 
methods considered alone. There are also numerous other types of machine learning 
techniques that could be applied to PET segmentation, such as random forest, support 
vector machines, or even deep learning techniques 91, which have been applied to the task of 
image segmentation in other modalities such as MRI or CT 92, 93. Although these approaches 
are promising for the future of PET image segmentation, the use of these techniques for PET 580 
is currently rather scarce in the literature 94. Today these techniques are exploited to classify 
patients in terms of outcome based on characteristics extracted from previously delineated 
tumors95, 96. 
PET-AS algorithms can be trained on pathological findings or physician contours. The 
advantage of training an algorithm using these contours is that additional information, not 585 
present in the PET image, is taken into account since the physician draws contours based on 
additional a priori information (anatomical imaging, clinical data, etc.). On the other hand, 
training algorithms using physician contours can be biased by the particular physician’s 
background, goals, or misconceptions.  
 590 
One of the most used approaches to extract image features that can be used for 
segmentation is texture analysis. Uptake heterogeneity in PET images can be characterized 
by using regional descriptors such as textures. Unlike intensity or morphological features, 
textures represent more complex visual patterns composed of entities or sub-patterns, that 
have unique characteristics of brightness, color, slope, size, etc.97 “Image texture” can refer 595 
to the relative distribution of gray levels within a given image neighborhood. It integrates 
intensity with spatial information resulting in higher order histograms when compared to 
common first-order intensity histograms. Texture-based algorithms heavily use image 
statistical properties; however, since human visual perception often relies on subtle visual 
properties, such as texture, to differentiate between image regions of similar gray level 600 
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intensity, they are separated from the iterative, model-based approaches described in the 
previous section.  
Furthermore, the human visual system is limited in its ability to distinguish variations in 
gray tone and is subject to observer bias. Variation in image texture can reflect differences in 
underlying physiological processes such as vascularity or ordered/disordered growth 605 
patterns. The use of automated computer algorithms to differentiate tumor from normal tissue 
based on textural characteristics offers an objective and potentially more sensitive algorithm 
of tumor segmentation than those based on simple image thresholds. Among the methods 
that have been suggested to calculate image texture features are those based on (1) Gabor 
filters, (2) discrete wavelet transforms (DWT), (3) the co-occurrence matrix, (4) neighborhood 610 
gray-tone difference matrices (NGTDM) and (5) run-length matrices.  
Gabor filters98 and DWT99 measure the response of images to sets of filters at varying 
frequencies, scales and orientations. The Gabor filter (a Gaussian phasor), using a bank of 
kernels for each direction, scale and frequency, can produce a large number of non-
orthogonal features, which makes processing and feature selection difficult. DWTs take a 615 
multi-scale approach to texture description. Orthogonal wavelets are commonly used 
resulting in independent features. DWT, however, have had more difficulty discriminating 
fractal textures with non-stationary scales100.  
The co-occurrence matrices proposed by Haralick, et al. 101 and spatial gray level 
dependence matrix (SGLDM) features, are based on statistical properties derived from 620 
counting the number of times pairs of gray values occur next to each other. These are 
referred to as “second-order” features because they are based on the relationship of two 
voxels at a time. The size of a co-occurrence matrix is dependent on the number of gray 
values within a region. Each row (i) and column (j) entry in the matrix is the number of times 
voxels of grey values i and j occur next to each other at a given distance and angle. Higher 625 
order features refer to techniques that take into account spatial context from more than two 
voxels at a time. Amadasun and King proposed several higher order features based on  
NGTDM102. For every gray level i, the difference between this level, and the average 
neighborhood around it, is summed over every occurrence to produce the ith entry in the 
NGTDM.  630 
Another category of higher order features makes use of “run-length matrices.” In this 
case, analysis of the occurrence of consecutive voxels in a particular direction with the same 
grey level is used to extract textural descriptors such as energy, homogeneity, entropy, 
etc.103 However, run-length matrices are a computationally intensive means of deriving 
texture descriptors103.  635 
Although textural features have been used to characterize uptake heterogeneity 
within tumors after the segmentation step15,96 their use as a means of automatic 
segmentation can also provide additional information beyond simple voxel intensity that may 
improve the robustness of delineation criteria. This has been shown in multiple modalities 
including ultrasound (US) 104 and MRI105. PET and CT textures in the lung have been used in 640 
a series of applications including differentiating between malignant and benign nodes106, 107, 
judging treatment response15, 16, diagnosing diffuse parenchymal lung disease108-110, 
determining tumor staging, detection and segmentation111. With dual modality PET/CT 
systems (also PET/MRI in the near future112, 113), it is also possible to make use of image 
textures from PET and CT (MRI) in combination to improve image segmentation results. 645 
However, this leads to including anatomy for tumor volume characterization, instead of 
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characterizing the functional part of the tumor only. In two separate studies, combinations of 
PET and CT texture features in images of patients with H&N cancer114 and those with lung 
cancer71 improved tumor segmentation with respect to the dual modality ground truth, versus 
using PET and CT separately. This is discussed in more detail in section II.B.4 below. 650 
 
Within the learning category would also fall the recent approaches to account for a set 
or contours generated via multiple automatic methods, through averaging/consensus 
methods, 84 statistical methods such as the “inverse–ROC (receiver operating characteristic)“ 
approach,115 STAPLE (simultaneous truth and performance level estimation)-derived 655 
methods116, majority voting117, or decision tree83 to generate a surrogate of truth.  Most of 
these methods would need some type of “training” or preliminary determination of 
parameters for the particular type of lesions and may therefore avoid the limitations of the 
individual methods used. 
 660 
II. B. 3. Combined with image processing and/or reconstruction 
 
The limited and variable resolution of PET scanners, which results in anisotropic and 
spatially variant blur affecting PET images, leads to PVE, spill-in and spill-out of activity in 
nearby tissues17 and is therefore one of the main challenges for segmentation and for uptake 665 
quantification of oncologic lesions. In principle, all the segmentation strategies not explicitly 
intended for blurred images, but widely used for imaging modalities less affected by PVE 
than PET (e.g., thresholding, region growing, gradient-based algorithms, etc.),118 can be 
applied to PET images after a PVE recovery step119. PVE recovery can be performed after120-
124
 or during image reconstruction with algorithms taking into account a model of the scanner 670 
PSF125-127. These images however, should be handled with caution since PVE recovery 
techniques can introduce artifacts (e.g., variance increase related to Gibbs phenomena). The 
accuracy of PVE-recovered images can be improved by introducing regularizations such as a 
priori models, constraints or iteration stopping rules. An approach of this kind has been 
followed by Geets, et al.37 (described in section II.B.2.a) where a gradient-based 675 
segmentation algorithm was applied on deblurred and denoised images. In order to avoid 
Gibbs phenomena artifacts near the edges, deconvolution was refined with constraints on the 
deconvolved uptake. 
An alternative approach to account for blur is to model it explicitly in the segmentation 
procedure. For example, FLAB69, described in section II.B.2.c, or FHMC (Fuzzy Hidden 680 
Markov Chains)68, parameterize a generic form of uncertainty in order to assign special 
intermediate classes for the blurry borders of the main classes. Such algorithms, if combined 
with a post-segmentation PVE recovery technique for objects of known dimension/shape, like 
recovery coefficients, geometric transfer matrix17 or VOI-based deconvolution128, may also be 
able to provide an estimate of PVE-recovered lesion uptake inside the delineated borders129. 685 
Another means to account for PVE recovery in segmentation is to model it in an 
iterative process. The lesion border estimate can be iteratively refined using the result of the 
PVE recovery inside the lesion area and vice versa. Such an approach can potentially 
improve the estimation accuracy while providing a joint estimate of lesion borders and 
uptake. This approach was originally proposed by Chen, et al. for spherical objects130. More 690 
recently De Bernardi, et al. have further developed the idea by proposing a strategy that 
combines segmentation with a PVE recovery step obtained through a targeted maximum 
likelihood (ML) reconstruction algorithm with PSF modeling in the lesion area38. A scheme of 
the approach is shown in figure 2. 
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 695 
Fig.2. A schematic representation of the algorithm proposed by De Bernardi, et al.38, which 
combines segmentation and PVE recovery within an iterative process. 
To reduce blur in the latter approach, algorithms using transition regions between lesion 
and background are employed. These regions correspond to spill-out due to PVE and are 
modeled by regional basis functions in the PVE recovery reconstruction step. The 700 
reconstruction adjusts the activity inside each region according to the ML convergence with 
respect to the sinogram data. The subsequent segmentation refinement step acts on the 
lesion borders in the improved image, until borders no longer change. A requirement of the 
algorithm is that a model of the scanner PSF and access to raw data are available. 
Conversely, the advantage is that a joint estimate of lesion borders and activity can be 705 
obtained.  
In the work of De Bernardi, et al.38 the segmentation was obtained by using k-means 
clustering and the refinement was achieved by smoothing the result with the local PSF and 
by re-segmenting. The algorithm, suited for the simplest case of homogeneous lesions, was 
validated in a sphere phantom study. More recently, an improved strategy was proposed, in 710 
which the segmentation is performed with a Gaussian Mixture Model and PVE recovery is 
performed on a mixture of regional basis functions and voxel intensities. The algorithm was 
validated on a phantom in which lesions are simulated with zeolites (see section  IV.C.1)131. 
 
II.B.4. Segmentation of multimodality images  715 
Multimodality imaging is of increasing importance for cancer detection, staging and 
monitoring of treatment response132-136.  
In radiotherapy treatment planning, significant variability can occur when multiple 
observers contour the target volume137. This interobserver variability has been shown to be 
reduced by combining information from multimodality imaging and performing single 720 
delineations on fused images, such as CT and PET, or MRI and PET25, 138-142. However, 
traditional visual assessment of multimodality images is subjective and prone to variation. 
Alternatively, algorithms have been proposed for integrating complementary information into 
multimodality images by extending semi-automated segmentation algorithms into an 
interactive multimodality segmentation framework to define the target volume31-34.  725 
Consequently, the accuracy of the overall segmentation results would be improved, 
although, as a word of caution, it should be emphasized that the goal may be different from 
mono-modality delineation and its realization would depend on the application endpoint 
combined with the clinical association objective of the different image modalities. For 
instance, in radiotherapy planning, the main rationale behind the use of combining several 730 
images of different modalities to define the GTV is that they complement each other by 
combining different aspects of the underlying biology, physiology and/or anatomy. However, 
PET volume
Initial lesion 
segmentation
Segmentation 
refinement step     
PVE-recovery 
step 
Change?
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Exit
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Sinograms PSF modelling
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in reality, this may not be the case for all patients and all pathologies, for example the lesion 
may not be seen in the additional modality, or may exhibit an artifact. In addition, 
misregistration between the different modalities and respiratory motion may lead to a 735 
potentially erroneous GTV if the images were simply fused without careful consideration of 
geometric correspondence and the logic by which the different image data are combined 
(union, intersection or other forms of fusion). 
Exploitation of multimodal images for segmentation has been applied to define 
myocardial borders in cardiac CT, MRI and ultrasound using a multimodal snake deformable 740 
model143. Another example is the classification of coronary artery plaque composition from 
multiple contrast MRI images using a k-means clustering algorithm144. To define tumor target 
volumes using PET/CT/MRI images for radiotherapy treatment planning, a multi-valued 
deformable level set approach was used as illustrated in Figure 331. This approach was 
extended further later on using the Jensen Renyi divergence as the segmentation metric 34. 745 
 
Fig. 3. (a) PET/CT images of a patient with lung cancer in case of atelectasis (lung collapse), 
with manual segmentation for CT (orange), PET (green) and fused PET/CT (red). (b) The 
multi-valued level sets (MVLS) algorithm initialized (white circle), evolved contours in steps of 
10 iterations (black), and the final contour (red). (c) MVLS results shown along with manual 750 
contour on the fused PET/CT. (d) MVLS contour superimposed on CT (top) and PET 
(bottom). Reproduced with permission from El Naqa, et al.31. 
Mathematically, approaches that aim at simultaneously exploiting several image 
modalities represent a mapping from the imaging space to the ”perception” space as 
identified by experts such as radiation oncologists64. Several segmentation algorithms are 755 
amenable to such generalization145. Among these algorithms are multiple thresholding, 
clustering such as k-means and fuzzy c-means (FCM) and active contours. In the case of 
multiple thresholding, CT volumes can be used to guide selection of PET thresholds 46 or 
using thresholds on the CT intensities to constrain the PET segmentation145. These 
conditions are typically developed empirically but could be optimized for a specific 760 
application. For clustering, the process is carried out by redefining the image intensities and 
(b) (c) (d)
GTV-CT
GTV-PET
GTV-PET/CT
GTV-CT
GTV-PET
GTV-PET/CT
Initialization
MVLS
(a) CT
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clustering centers as vectors (with elements being the intensities of the different modalities) 
in contrast to the typical scalars used in single modality images144. The formalism for FCM is 
given in Appendix I. However, both thresholding and clustering algorithms in their basic form 
suffer from loss of spatial connectivity, which is accounted for in active contour models by 765 
using a continuous geometrical form such as the level sets. The level set provides a 
continuous implicit representation of geometric models, which easily allows for adaptation of 
topological changes and its generalization to different image modalities. Assuming there are 
N imaging modalities, then using the concept of multi-valued level sets (MVLS)146, 147 the 
different imaging modalities are represented by a weighted level set functional objective of 770 
the different modalities and the target boundary is defined at the zero level set31 (Appendix I). 
Finally, other approaches based on the Markov field combined with graph-cut methods32, as 
well as random walk segmentation33 or including topology80, were developed and validated 
on clinical images, for multi-modal (PET, CT, MRI) images tumor segmentation, with 
promising results.  775 
II.B.5. Vendor implementations 
 Here we provide a brief summary of the vendor implementations of PET-AS methods 
at the time when this report was written. Therefore, it may not describe the PET-AS methods 
provided by the vendors at the time of publication due to constant evolution of vendor 
software. Vendors also provide tools for manual segmentation that have been omitted for 780 
brevity. Since the algorithms implemented by vendors are not exactly known, the summary 
and classification provided below do carry a significant degree of uncertainty.   
Gradient based edge detection tool is avaible by MIM Software Inc. (Cleveland, OH, 
see Section II.B.2 a) and Table 1,63,148). VelocityAI (Varian Medical Systems|Velocity Medical 
Solutions, Atlanta, GA) also point that their tool uses “rates of spatial change” in the 785 
segmentation process. PET-AS methods based on region growing tools (Section II.B.2 b) are 
available by Mirada XD (Mirada Medical, Oxford, UK) and RayStation (RaySearch 
Laboratories AB, Stockholm, Sweden).   
Adaptive thresholding approaches (Setion II.B.1) are available by VelocityAI (the 
method by Daisne, et al.149) , GE Healthcare VCARTM system (V 1.10) (GE Healthcare Inc., 790 
Rahway, NJ, the method by Sebastian, et al.74,see Table 1), and ROVER (ABX GmbH, 
Radeberg, Germany, an iterative approach following Hofheinz et al26, 61 ). 
Finally, practically all vendor implementations use some type of fixed or adaptive 
threshold based method (Setion II.B.1). For example, Varian’s Eclipse V.10 (Varian Medical 
Systems, Inc., Palo Alto, CA) as well as other vendor implementations including Philips 795 
Healthcare PinnacleTM (Philips Healthcare, Andover, MA) and Raystation allow users to 
perform PET segmentation using thresholding in different units (Bq/ml or different SUV 
definitions), and percent from peak SUV.   
  
III. COMPARISON OF THE PET-AS ALGORITHMS BASED ON 800 
CURRENT PUBLICATIONS    
A comparison of PET-AS algorithms based on published reports is difficult and subject 
to controversy because each algorithm has been developed and validated (and often 
This	article	is	protected	by	copyright.	All	rights	reserved
Au
th
or
 M
an
us
cr
ip
t
 23 
 
optimized) on different datasets, often using a single type of scanner and/or processing 
software. However, some limited conclusions can be drawn. For instance, it is possible to 805 
compare the algorithms based on their level of validation as well as those algorithms that 
have been applied to the same datasets. Table 2 contains a survey of various papers in 
which several algorithms were compared, providing the type of datasets and methods used, 
the conclusions of the study, as well as some comments. 
Most of the algorithms have been optimized/validated on phantom acquisitions of 810 
spheres, as this is a common tool in PET imaging to evaluate the sensitivities, noise 
properties and spatial resolution of PET scanners. On one hand, most algorithms usually 
give satisfactory results in these phantom acquisitions, even for varying levels of noise and 
contrast levels. However, homogeneous spheres on a homogeneous background are not 
realistic tumors. The number of algorithms that have been successfully applied to realistic 815 
simulated tumors or real clinical tumors with an acceptable surrogate of truth (e.g., 
histopathological measurements) is much smaller. Finally, algorithms that have been 
validated for robustness against several scanner models and their associated reconstruction 
algorithms are even less numerous since the datasets are not usually made publicly 
available. 820 
It should also be emphasized that there are a few algorithms that have been applied to 
common (although not publically available) datasets. For instance, the gradient-based 
algorithm by Geets, et al.37, the improved fuzzy c-means (FCM) by Belhassen and Zaidi28, 150, 
the theory of possibility applied to Maximum intensity projections (MIP) by Dewalle-Vignon, et 
al.65 and the Contourlet-based active contour model by Abdoli, et al.78 have all been applied 825 
to a dataset of seven patients with 3D reconstruction of the surgical specimen in histology 
(from a dataset of nine patients originally obtained in a study by Daisne, et al.151), with 
19±22%, 9±28%, 17±13% and 0.29±0.6% volume mean errors, respectively. Similarly, the 
improved fuzzy c-means by Belhassen, et al. 28, FLAB by Hatt, et al.70,152 and the level sets 
and Jensen-Rényi divergence algorithm by Markel, et al.34 were applied to the NSCLC 830 
tumors dataset with maximum diameters from MAASTRO (Maastricht Radiation Oncology)139 
(with ±6% error for FLAB, ±15% for the improved FCM and ±14.8% for the level sets 
approach, respectively). In addition, most of the advanced algorithms that have been 
proposed have been compared to some kind of fixed and/or adaptive thresholding using their 
respective test datasets and have, for the most part, demonstrated improvements in 835 
accuracy and robustness. In particular, it was observed that fixed and adaptive thresholding 
might lead to over 100% errors in cases of small and/or low-contrast objects and significant 
underestimation (-20 to -100%) in cases of larger volumes with more heterogeneous uptake 
distributions, whereas advanced methods were able to provide more satisfactory error rates 
(around or below 10 to 20% errors)152,153. However, it is possible that simpler, e.g., adaptive 840 
threshold PET-AS-methods optimized for a specific body site, may perform comparably well 
or even better than some of the more advanced techniques154. 
 In the largest comparison to date, Shepherd, et al. 115 segmented 7 VOIs in PET using 
variants of threshold-, gradient-, hybrid image-, region growing- and watershed-based 
algorithms, as well as more complex pipeline algorithms. Along with manual delineations, a 845 
total of 30 distinct segmentations were performed per VOI and grouped according to type 
and dependence upon complementary information from the user and from simultaneous CT. 
According to a statistical accuracy measure that accounts for uncertainties in ground truth, 
the most promising algorithms within the wider field of computer vision were a deformable 
contour model using energy minimization techniques, a fuzzy c-means (FCM) algorithm and 850 
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an algorithm that combines variants of region growing and the watershed transform. Another 
important finding was that user interaction proved in general to benefit segmentation 
accuracy, highlighting the need to incorporate expert human knowledge, and this in turn was 
made more effective by visualization of PET gradients or CT from PET-CT hybrid imaging. 
There is little information to date concerning the comparison of the performance of an 855 
algorithm using datasets from different scanners and/or with the implementation of that 
algorithm in different software packages. In one study155, an adaptive threshold segmentation 
algorithm was applied in three centers using two similar types of scanners from the same 
manufacturer. The authors demonstrated that significant differences were observed in the 
optimal threshold values depending on the center and imaging protocols, despite that both 860 
the scanner and reconstruction method were the same. In addition, significant differences 
were also observed, depending on the reconstruction settings (Fig. 4). They concluded that 
synchronization of imaging protocols can facilitate contouring activities between cooperating 
sites. In another investigation, dependence of the segmentation threshold providing the 
correct sphere volume on the reconstruction algorithm was also observed for small 865 
spheres156.   
In a German multicenter study157, Schaefer, et al. evaluated the calibration of their 
adaptive threshold algorithm (contrast-oriented algorithm) for FDG PET-based delineation of 
tumor volumes in eleven centers, using three different scanner types from two vendors. They 
observed only minor differences in calibration parameters for scanners of the same type, 870 
provided that identical imaging protocols were used, whereas significant differences were 
found between scanner types and vendors. After calibrating the algorithm for all three 
scanners, the calculated SUV thresholds for auto-contouring did not differ significantly.  
On the other hand, the FLAB algorithm by Hatt, et al. showed robustness to scanner 
type and performed well without pre-optimization, on four different scanners from three 875 
vendors (Philips GEMINI GXL and GEMINI TF, Siemens Biograph 16 and GE Discovery LS) 
using a large range of acquisition parameters such as voxel size, acquisition duration and 
sphere-to-background contrast.43 
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Fig. 4: Variation of the optimal threshold value (y axis) obtained according to different 880 
settings of the PET reconstruction with varying number of iterations and subsets (from 2 
iterations 1 subset to 8 iterations 8 subsets, colored bars), and for spheres of different 
volumes (x axis) and a sphere-to-background ratio of 3.5, for one single scanner model. 
Reproduced with permission from Ollers, et al.155   
While the natural incentive is to create algorithms which perform universally well across body 885 
sites and disease types, for at least one body site it was shown154 that simpler (e.g., adaptive 
threshold) methods may perform comparably well if specifically optimized for these 
conditions. At present there is not a sufficient amount of published data to give specific 
recommendations for each clinical site. The emerging consensus84 and decision tree83 based 
methods however, provide a potential to provide adequate solution for each site if 890 
appropriately adapted and trained. 
Given the above results, the validation of PET-AS algorithms, as described in current 
publications, does not provide sufficient information regarding which of the known 
approaches would be most accurate, applicable, or convenient for clinical use. In the 
following sections, we attempt to lay the basis for a framework that avoids the methodological 895 
weaknesses of the past and addresses the challenges inherent in segmentation in PET. 
Table 2. A summary of segmentation method comparisons and  reviews.  
No. Reference Compared 
methods 
Images or 
Phantoms 
used 
Results and/or 
recommendations 
reported by the 
authors 
Limitations and 
comments by 
TG211 or others 
as cited 
Comparison studies 
1 Nestle, et 
al. 200523 
Visual 
segmentation, 
40% of 
SUVmax 
threshold, 
SUV>2.5 
threshold, and 
an adaptive 
threshold 
Patient scans Large differences 
between volumes 
obtained with the 4 
approaches 
Only visual 
segmentation 
used as a 
surrogate of truth 
and only clinical 
data. 
2 Schinagl, 
et al. 
2007158 
Visual 
segmentation, 
40% and 50% 
of SUVmax 
threshold, and 
adaptive 
thresholding 
78 Clinical 
PET/CT 
images of 
head and neck 
The 5 methods led 
to very different 
volumes and shapes 
of the GTV. Fixed 
threshold at SUV of 
2.5 led to the most 
disappointing 
results. 
The GTV was 
defined manually 
on CT and used 
as a surrogate of 
truth for PET-
derived delineation 
and only clinical 
data was used. 
3 Geets, et 
al. 200737, 
Wanet, et 
al. 201156 
Fixed and 
adaptive 
thresholding, 
gradient-
based 
segmentation 
Phantom 
(spheres), 
simulated 
images, clinical 
images of lung 
and H&N 
cancers with 
More accurate 
segmentation with 
gradient-based 
approach compared 
to threshold 
Numerous issues 
associated with 
the 3D 
reconstruction of 
the surgical 
specimen used as 
gold standard. 
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histopathology 
3D 
measurements 
4 Greco, et 
al. 2008159 
Manual 
segmentation, 
50% SUVmax, 
SUV>2.5 
threshold and 
iterative 
thresholding 
12 Head and 
neck cancer 
patients.  
Thresholding PET-
AS algorithms are 
strongly threshold-
dependent and may 
reduce target 
volumes significantly 
when compared to 
visual and 
physician- 
determined 
volumes.  
 
Limitations: 
reference GTVs 
defined manually 
on CT and MRI.  
5 Vees, et al. 
2009160 
Manual 
segmentation, 
SUV>2.5 
threshold, 
40% and 50% 
of SUVmax 
threshold, 
adaptive 
thresholding, 
gradient-
based method 
and region 
growing. 
18 Patients 
with high grade 
glioma  
PET often detected 
tumors that are not 
visible on MRI and 
added substantial 
tumor extension 
outside the GTV 
defined by MRI in 
33% of cases. 
The 2.5 SUV 
isocontour and 
“Gradient Find” 
“segmentation 
techniques 
performed poorly 
and should not be 
used for GTV 
delineation”. 
 
Ground-truth 
derived from 
manual 
segmentation on 
MRI only. 
6 Belhassen, 
et al. 
2009161 
Three 
different 
implement-
ations of the 
fuzzy C-
means (FCM) 
clustering 
algorithm 
Patient scans Incorporating 
wavelet transform 
and spatial 
information through 
nonlinear anisotropic 
diffusion filter 
improved accuracy 
for heterogeneous 
cases  
No comparison 
with other 
standard methods 
7 Tylski, et 
al. 201042 
Four different 
threshold 
methods (% 
of max activity 
and three 
adaptive 
thresholding), 
and a model-
Spheres in an 
antropomor-
phic torso 
phantom as 
well as non 
spherical 
simulated 
tumors 
Large differences 
between volumes 
obtained with 
different 
segmentation 
algorithms. Model-
based or 
background-
No clinical data, 
limited to 
threshold-based 
algorithms only, 
only volume error 
considered as a 
metric 
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based 
thresholding 
adjusted algorithms 
performed better 
than fixed 
thresholds. 
8 Hatt, et al. 
201070, 
201143, 152 
Fixed and 
adaptive 
thresholding, 
Fuzzy C-
means, FLAB 
IEC phantom 
(spheres); 
simulated 
images, clinical 
images with 
maximum 
diameter 
measurements 
in 
histopathology 
Advanced 
algorithms are more 
accurate compared 
to threshold- based 
and are also more 
robust and 
repeatable. 
For clinical 
images, only 
maximum 
diameters along 
one axis were 
available from 
histology. 
9 Dewalle-
Vignion, et 
al. 201165, 
2012162 
Manual 
segmentation, 
42% of 
SUVmax, 2 
different 
adaptive 
thresholding, 
fuzzy c-mean 
and an 
advanced 
method based 
on fuzzy set 
theory.  
Phantom 
images, 
simulated 
images, clinical 
images with 
manual 
delineations 
The advanced 
algorithm is more 
accurate and robust 
than threshold-
based and closer to 
manual delineations 
by clinicians 
Only manual 
delineation for 
surrogate of truth 
of clinical data.  
Comments: 
Interesting use of 
various metrics for 
assessment of 
image 
segmentation 
accuracy. 
10 Werner-
Wasik, et 
al. 201263  
Manual 
segmentation, 
fixed 
thresholds at 
25% to 50% 
of SUVmax (by 
5% 
increments) 
and gradient-
based 
segmentation 
IEC phantom 
(spheres) in 
multiple 
scanners, 
simulated 
images of lung 
tumors 
A gradient-based 
algorithm is more 
“accurate and 
consistent” than   
manual and 
threshold 
segmentation.  
Only volume error 
used as a metric 
of performance. 
“…manual 
verification using 
CT scan should be 
performed (…)  
GTV definition 
requires joint 
assessment by the 
radiologist, nuclear 
physician and 
radiation 
oncologist” 163 
11 Zaidi, et al. 
2012150 
Five 
thresholding 
methods, 
Standard and 
improved 
fuzzy c-
means, level 
set technique, 
Patient scans 
with 
histopathology 
3D 
measurements 
(same as #5 
above) N/A 
The automated 
Fuzzy c-means 
algorithm provided 
was shown to be 
more accurate than 
5 thresholding 
algorithms, the level 
set technique, the 
Numerous issues 
associated with 
the 3D 
reconstruction of 
the surgical 
specimen used as 
gold standard. See 
Table 1 
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stochastic 
EM. 
stochastic EM 
approach and 
regular FCM. 
Adaptive threshold 
techniques need to 
be calibrated for 
each PET scanner 
and acquisition/pro-
cessing protocol and 
should not be used 
without optimization.  
12 Shepherd, 
et al. 2012 
115
 
30 methods 
from 13 
different 
groups. 
Tumor and 
lymph-node 
metastases in 
H&N cancer 
and physical 
phantom 
(irregular 
shapes). 
Simulated, 
experimental 
and clinical 
studies 
Highest accuracy is 
obtained from 
optimal balance 
between interactivity 
and automation. 
Improvements are 
seen from visual 
guidance by PET 
gradient as well as 
by using CT.  
Limitation: a small 
number of objects 
(n=7) were used 
for the evaluation. 
13 Schaefer, 
et al. 
2012157 
 
One adaptive 
thresholding 
technique 
Phantoms, 
same 
threshold 
algorithm, 
different 
scanners  
The calibration of an 
adaptive threshold 
PET-AS algorithm is 
scanner and image 
analysis software- 
dependent.  
Confirmation of 
previous findings 
about adaptive 
threshold 
segmentation.  
14 Schinagl et 
al. 2013 164 
Visual, SUV 
of 2.5, fixed 
threshold of 
40% and 
50%, and two 
adaptive 
threshold 
based 
methods 
using either 
the primary or 
the 
metastasis  
Evaluation of 
the segmen-
tation of 
metastatic 
lymph nodes 
against 
pathology in 12 
head and neck 
cancer patients  
SUV of 2.5 was 
unsatisfactory in 
35% of cases; for 
the last four 
methods: i) using 
the node as a 
reference gave 
results comparable 
to visual 
ii) using the primary 
as a reference gave 
poor results;  
Shows the 
limitations of 
threshold based 
methods.  
15 Hofheinz, 
et al. 2013, 
61
 
Voxel-specific 
adaptive 
thresholding  
and standard 
lesion-specific 
adaptive 
threshold  
30 simulated 
images based 
on real clinical 
datasets. 
The  voxel-specific 
adaptive threshold 
method was more 
accurate than the 
lesion-specific one 
in heterogeneous 
cases 
Only simulated 
data were used. 
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16 Lapuyade-
Lahorgue, 
et al. 2015 
81
 
Improved 
generalized 
fuzzy c-
means, fuzzy 
local 
information C-
means and 
FLAB  
34 simulated 
tumors and 9 
clinical images 
with 
consensus of 
manual 
delineations. 3 
acquisitions of 
phantoms for 
robustness of 
evaluation.  
In both simulated 
and clinical images, 
the improved 
generalized FCM led 
to better results than 
another FCM 
implementation and 
FLAB, especially on 
complex and 
heterogeneous 
tumours, without any 
loss of robustness 
on data acquired in 
different scanners. 
Only 9 clinical 
images used. 
 
Reviews 
1 Boudraa, 
et al. 2006 
39
 
N/A Mostly clinical 
images  
Extensive review of 
the fomalism of 
image segmentation 
algorithms used in 
nuclear medicine (not 
specific to PET and 
clinical oncology) 
Only a few 
algorithms have 
been rigorously 
validated for 
accuracy, 
repeatability and 
robustness. 
2 Lee, 
201029 
 
N/A Simulated, 
mostly clinical 
images 
Discussed the main 
caveats of threshold- 
based techniques 
including the effect of 
phantom cold walls 
on threshold. A 
discussion of the 
available and 
desirable validation 
datasets and 
approaches is also 
included.  
Extensive review 
of nuclear 
medicine image 
segmentation 
algorithms (not 
specific to PET 
and clinical 
oncology) 
3 Zaidi and 
El Naqa, 
2010 54 
 
N/AN/A Simulated, 
experimental 
and clinical 
studies  
Despite being 
promising, advanced 
PET-AS algorithms 
are not used in the 
clinic.  
 
4 Hatt, et al. 
201123 
N/A  N/A Only a few algorithms 
have been rigorously 
validated for 
accuracy, 
repeatability and 
robustness. 
See the three last 
columns of Table 
1 
5 Kirov A.S, 
Fanchon, 
N/A  Clinical 
images with 
Articles comparing 
PET-AS methods are 
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pathology 
derived 
ground truth.  
summarized 
separately for lesions 
in five groups based 
on location in the 
body with a focus on 
the accuracy, 
usefulness and the 
role of the pathology-
validated PET image 
sets.  
6 Foster, et 
al. 201436  
N/A  N/A  “although there is no 
PET image 
segmentation method 
that is optimal for all 
applications or can 
compensate for all of 
the difficulties 
inherent to PET 
images, development 
of trending image 
segmentation 
techniques which 
combine anatomical 
information and 
metabolic activities in 
the same hybrid 
frameworks (PET-
CT, PET-CT, and 
MRI-PET-CT) is 
encouraging and 
open to further 
investigations.”  
Most exhaustive 
review of the 
state-of-the-art in 
2014. Uses a 
similar 
classification of 
methods as in the 
present report. 
 
IV. COMPONENTS OF AN EVALUATION STANDARD  
A main conclusion of the work of this task group is that a common and standardized 900 
evaluation protocol or ”benchmark” to assess the performance of PET–AS methods is 
needed. The design of such a protocol requires:  
- Selection of evaluation endpoint and definition of performance criteria; 
- Selection of a set of images; 
- Selection of contour evaluation tools; 905 
 IV.A. Evaluation endpoints   
 For the purpose of radiation therapy the PET image is most often used to segment the 
so called gross tumor volume (GTV) which contains the macroscopically observable 
(demonstrable) disease166. Based on the GTV is later generated the clinical target volume 
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(CTV), which is supposed to include additional volume with a high probability of microscopic 910 
tumor extensions166. The planning target volume (PTV) encompasses the CTV and adds and 
additional margin for set-up error and organ motion166. The sub-target volume (sub-GTV) lies 
within the GTV and locates one or more metabolically distinct sub-volumes such as tumor 
growth, burden or hypoxia. Segmentation of the sub-GTV assumes availability of additional 
functional information, which can come from PET or from other imaging modalities2. Within 915 
this context, the smallest number of cells with uptake that is possible to image using PET has 
been assessed as 105 cells167.   
The endpoint for evaluating PET-AS algorithms can be selected at different levels of 
approximation of the tumor border. We consider the following three levels of approximation 
ordered from least to most accurate:  920 
a) The PET avid tumor volume in the PET image as obtained through standard 
reconstruction, which typically leaves some of the physical artifacts (such as 
limited spatial resolution, motion), not routinely and/or fully corrected; 
b) The PET avid tumor volume after optimal correction of more subtle artifacts such 
as resolution, motion and noise;  925 
c) The spatial distribution of the biological quantity of clinical interest (e.g., the 
distribution of cells exhibiting a certain metabolic trait, e.g., proliferation).  
The ideal endpoint for evaluating PET-AS algorithms if they are to facilitate reaching the 
clinical goal is (c). However, variations in the biological environment of the lesion (e.g., 
perfusion and inflammation) and other biological and physical uncertainty in PET images 930 
decrease the accuracy of numerical algorithms in aiming at the clinical endpoint (e.g., the 
GTV). The less ambitious endpoint (b) of contouring the volume based on the real tracer 
distribution is feasible, provided that important factors, such as PVE, motion and noise are 
accurately taken into account or corrected with state-of-the-art approaches (either within 
reconstruction or post-reconstruction).  935 
Finally, most algorithms have been and can be evaluated against the activity as seen in 
the standard PET image (a). This case concerns standard acquisitions with routine clinical 
systems for which some of the physical artefacts (attenuation, scattered and random events, 
etc.) are corrected, but no correction is applied for others (e.g., spatial resolution, motion, 
statistical noise and post-filtering). This method is currently widely used. Nevertheless, for 940 
future standardized evaluation protocols, our task group recommends considering the three 
endpoints listed above168. Such future work should also consider segmenting radiotherapy 
targets using multi-spectral images from hybrid imaging studies31, 33 ,34,114, dynamic imaging75, 
169
 and/or multi-tracer PET images170.  
IV.B. Definition of performance criteria: accuracy, precision (reproducibility and 945 
repeatability) efficiency and robustness 
In instrumental science any measurement tool can be characterized by its accuracy 
(degree of closeness to the true value) and precision (degree to which repeated 
measurements under unchanged conditions give the same results). Precision can be further 
stratified into repeatability and reproducibility. Reproducibility often implies that tools or 950 
operators are different, whereas repeatability relies on experimental conditions that are kept 
as identical as possible. For complex tools such as segmentation algorithms, stratification 
into reproducibility and repeatability is not necessary and precision suffices, provided all 
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parameters are identified, including those for which the operator has control, e.g., the region 
of an image used to characterize the background tracer uptake. 955 
For a given segmentation algorithm we define accuracy as the correctness of retrieving 
the true 3D object spatial extent, shape and volume based on the reconstructed activity 
distribution in a PET image, irrespective of the correlation between this distribution and the 
underlying physiological process. This means that an image segmentation algorithm is not 
expected to differentiate specific from non-specific tracer uptake (e.g., inflammation and 960 
tumor in the case of FDG) if they are of the same intensity. 
Within the context of this report, repeatability1 is defined as the ability of a given 
algorithm to reach the same result when applied multiple times on a single image replicate 
(single acquisition), given potentially differing algorithmic initializations. In such a task, 
deterministic, fixed threshold approaches will always give the same result when applied to a 965 
given image. On the other hand, more advanced algorithms are susceptible to providing 
different results when applied with multiple runs on the same image because they could rely 
on more complex initializations or estimation processes, including random ones. 
We define robustness as the ability of a given algorithm to generate consistent, 
segmented volumes under varying acquisition and image reconstruction conditions, including 970 
issues related to statistical counts and multiple replicates (multiple acquisition of the same 
object) due to noise. This robustness is determined as the variability of the segmentation 
results when a PET-AS algorithm is applied on images of the same object acquired using 
various scanners, and for each scanner, under various contrast and noise conditions, using 
different reconstruction and associated correction algorithms. 975 
Finally, an important parameter of the algorithms is their efficiency, which may 
determine their practical viability41. Efficiency includes workflow and computational 
complexity required for completion of the segmentation task. Considering the computing 
power evolution and possibilities (parallel computing, graphical processing units, etc.) the 
main limiting factor is workflow and human interaction. 980 
 Below is laid out the vision of the task group for a future standard for PET-AS method 
evaluation. It has two main components: 1) Benchmark image set; 2) Performance evaluation 
criteria. 
IV.C. Benchmark image sets 
This section is dedicated to the selection of the benchmark images, which should cover 985 
a realistic range of parameters so that it ensures that the tested PET-AS algorithms can meet 
the challenges that may be encountered in various clinical cases. However, in order to allow 
for a practical and realistic evaluation and interpretation of the results, the number of images 
and datasets should be kept to a minimum. Therefore, the images that are likely to offer the 
most realistic, rigorous way to assess the performance of the various algorithms should be 990 
selected. A classification of the possible types of benchmark images is given in Table 3. 
                                               
1
 The term reproducibility or repeatability is also used to denote the variability assessed using double 
baseline PET scan acquisitions (repeated acquisitions at a few days interval without treatment). This 
“physiological” reproducibility is a different topic than the repeatability/reproducibility of the PET-AS 
algorithm discussed here. 
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Table 3.  Advantages and disadvantages of the different methods used for generation of test 
images. 
 
Experimental images Simulated images 
Simple 
Phantoms 
Realistic 
phantoms 
Clinical 
images 
Forward 
Projected 
Images 
Monte Carlo 
(MC) 
Simulations 
Advantages:  Exact 
representation 
of the scanner 
resolution, 
image noise 
and other 
image artifacts  Ground truth 
accurately 
known  Easy to 
generate and 
use 
 Exact 
representation of 
the scanner 
resolution, 
image noise and 
other image 
artifacts  Capable to 
produce  lesion 
shapes 
corresponding to 
actual tumors  Known ground 
truth 
 Exact 
representation of 
the scanner 
resolution, image 
noise and other 
image artifacts  Real tumors 
 
 Precise experimental 
control  Flexibility in phantom 
design  Precise knowledge of 
the reference object  Computationally 
cheap 
 Precise experimental 
control   Realistic count 
distributions  Flexibility in phantom 
design  Precise knowledge of 
the reference object  Camera-specific 
information 
Dis-
advantages: 
 The objects 
have simplistic 
and unrealistic 
shape and 
activity 
distribution  Most with few 
exceptions171, 
172
 have cold 
walls 
 
 Some 
uncertainties in 
the experiment 
can be hard to 
quantify  Difficult to 
generate 
inhomogeneous 
activity  Labor intensive 
 Uncertainties in 
the knowledge of 
the reference 
object, even with 
histopathology 
reference  
 
 Scatter count 
distributions and 
noise are usually less 
accurately modeled  Detailed physics and 
system information 
ignored 
 Computationally 
expensive  Model requires 
extensive up front 
experience 
 
The advantages and disadvantages of the different classes of datasets and of particular 995 
published image sets are discussed in more detail below. The various phantoms considered 
for a common PET-AS evaluation protocol are summarized in Appendix III. 
IV.C.1 Physical phantoms 
The main advantage of physical phantoms is that they contain the same exact 
degradations, namely resolution, noise, scatter, etc., as clinical PET scans, while also 1000 
ensuring that the ground truth is both reproducible and known for repeated testing using 
prescribed conditions. 
Most PET-AS algorithms are initially developed and optimized against simple phantoms 
containing uniform activity spheres or cylinders. Therefore, these phantoms are essential in 
evaluating segmentation accuracy for well-defined, simple-shaped objects. However, 1005 
spherical targets oversimplify the segmentation problem and can erroneously favor an 
algorithm that would break down in the presence of a complex topology or heterogeneous 
tracer uptake distribution seen in real tumors. Testing the PET-AS algorithms against these 
images can nevertheless provide: 1) assurance that the algorithms compared are trustworthy 
for simple cases; 2) agreement limits for initial, basic evaluation; 3) opportunity for verifying 1010 
algorithm operation over time (e.g., routine quality assurance) and 4) a convenient tool for 
testing the robustness of the algorithms under different experimental conditions (Fig. T.A2.1 
in Appendix III) using for instance the National Electrical Manufacturers Association  (NEMA) 
This	article	is	protected	by	copyright.	All	rights	reserved
Au
th
or
 M
an
us
cr
ip
t
 34 
 
image quality phantom173, available in most PET centers. However, with few exceptions171,172 
these phantoms contain objects with cold walls in a homogeneous background173. 1015 
Furthermore, most of the algorithms have already been optimized and assessed on these 
simplistic, physical phantom acquisitions at the development stage. 
More realistic phantoms are of interest for more demanding evaluations with respect to 
the activity distribution endpoint. The contribution by Zito, et al.174 regarding the use of 
phantoms containing zeolites (microporous, aluminosilicate minerals commonly used as 1020 
commercial adsorbents which can absorb aqueous solutions of (18)F-FDG) is promising. 
This phantom allows tumor-like objects to be generated with any desired shape, size and 
contrast levels without cold walls. They also provides ground truth with sub-voxel resolution 
that is available from the associated co-registered CT images.       
A limitation of these images (e.g. obtained from zeolite phantoms) is the lack of control 1025 
and knowledge of the potential heterogeneity of the tracer uptake in the background and the 
"tumor." Several alternatives allow experimental modeling of non-uniform activity inside the 
lesions and in the background. These phantoms include structures generated by stacking 
paper sheets containing PET images printed with radioactive ink175, 176 (see Fig.T.A1.6. in 
Appendix III), or 3D printers using radioactive ink177. Another option for generating non-1030 
uniform uptake distributions is the use of thin sheets to displace activity (see Fig.T.A1.7 in 
Appendix III)178.  
IV.C.2 Simulated images 
Virtual or numerical phantoms associated with a PET-image generation process 
represent an inexpensive, precise way to test PET software and clinical methodologies179. 1035 
One definition of a virtual or numerical PET simulation framework corresponds to any 
computer-generated object that is processed to produce a PET-like image. It should be clear 
that virtual phantoms are distinct from the resulting PET images and represent a reference 
source distribution from which the PET-like image is produced. In order to be useful the 
resulting image needs to be representative of what is observed in the images produced by a 1040 
real PET camera. 
Generating PET-like images for virtual phantoms can be done in several ways. Below 
we describe methods that range from simple to complex, as more realism is included in the 
simulation, and therefore, in the produced images.  
Inserted Tumor PET-Like Images:   1045 
The simplest method is to insert an object with added noise, representing a tumor, 
directly into an existing PET image180. However, this method requires considerable effort to 
blend the noise and edge characteristics of the lesion into the image in order to avoid 
obvious edges from threshold or texture mismatches. This method is the least realistic of the 
various approaches for generating PET-like images. Because of these weaknesses and the 1050 
difficulties in accurately matching the noise/spatial resolution properties of real PET images, 
it is not further discussed.  
Forward Projected Tumors:  
Alternatively, a more robust method is to consider a synthetic lesion that can be forward 
projected, have noise added and then inserted into the noiseless forward-projection of the 1055 
existing PET image that is scaled appropriately to match the desired noise level of the tumor. 
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The projection data can then be reconstructed to preserve the basic characteristics of the 
original image. Care must be taken to ensure that the forward and backward projectors are 
matched, i.e., adjoint, that the original PET image is sufficiently oversampled and that the 
reconstruction process does not greatly alter the underlying PET image. Although this 1060 
process is conceptually simple, its realism is limited by inaccuracies introduced in modeling 
the spatial variation of the PSF, the noise model and the effects of the reconstruction 
process. 
Forward Projected Phantom Images:  
Forward projected phantoms and tumors represent a middle ground between full Monte 1065 
Carlo PET simulations of phantoms and directly inserting tumors into PET images. This has 
been implemented in an open source simulation tool181 and used in several PET studies, as it 
is a standard means for evaluating image reconstruction methods182, 183. 
In this method, noiseless tumor and phantom images are forward projected and scaled 
to produce a similar number of total counts as would be seen in the equivalent projection 1070 
data and then fused, which represents the reference images. Noise is then added to the 
resulting projection data via a Poisson distribution to create PET-like projection data. These 
data are then reconstructed to produce the PET-like images of the original virtual phantom. 
Additional realism can be included by blurring the images with a PSF (derived from physical 
parameters: positron range, annihilation photon non-collinearity, detector solid angle, block 1075 
effects, etc.), adding attenuation, random and scatter counts and altering the fidelity of the 
projection matrix or the type of reconstruction. This process is described in Figure T.A1.8. in 
Appendix III. Motion can also be simulated by applying the appropriate motion-blurring kernel 
to the image prior to forward projecting the image into sinogram space. This method can be 
extended to insert realistic tumors into existing PET images181. 1080 
Monte Carlo simulations:  
 The most realistic data can be obtained by simulating the entire positron emission, 
annihilation, interaction and detection processes with Monte Carlo (MC) simulations. The 
subsequent projection data can be reconstructed to produce very realistic images.  
Using recent, state-of-the-art anthropomorphic phantoms such as the XCAT (4D 1085 
NURBS-based Cardiac-Torso)184 or Zubal phantoms184, 185 and MC simulators such as 
SORTEO (Simulation Of Realistic Tridimensional Emitting Objects) 186, GATE (Geant4 
Application for Tomography Emission)187, 188 or SimSET (Simulation System for Emission 
Tomography)189, combined with scanner system modeling (geometry, detectors, etc.)190, can 
provide highly realistic simulations, including respiratory motion153 with regular or irregular 1090 
respiratory signals. Simulated tumors can be placed in various anatomical locations and 
generated with non-spherical shapes and complex uptake distributions, including realistic 
“activity gradients” (see Figure T.A1.9 in Appendix III). PET data are then simulated by 
assigning an uptake to each organ/tumor of the anatomical phantom. Parameters such as 
tumor-to-background or intra-tumor heterogeneities can be varied within any desired range. 1095 
Similarly, it is possible to generate various noise realizations, as well as various SNR ratios, 
by selecting different parts of the overall simulated list mode data (lines of response) before 
reconstruction. It is therefore also possible to select lines of response corresponding to true 
coincidences only, or including the random and scattered data. Different scanner designs 
and reconstruction algorithms and/or parameters (number of iterations, post-filtering 1100 
smoothing, voxel dimensions, etc.) can also be modeled if detailed information about the 
This	article	is	protected	by	copyright.	All	rights	reserved
Au
th
or
 M
an
us
cr
ip
t
 36 
 
scanner is available; hence this method allows the assessment of robustness and 
“universality” of the PET-AS algorithms. 
Simulated data can provide a high level of realism without the disadvantages and 
inconveniences of real phantom acquisitions. It is possible to increase the number of activity 1105 
levels to realistic numbers approximating ground truth to the voxel level achievable by some 
experimental approaches.177, 178 This however can increase the complexity and time required 
for the design of the simulation. 
IV. C.3.  Clinical images  
In patients, the “ground truth” is defined by the actual underlying extent of disease; 1110 
however, the true biological margins are usually unknown. This is in contrast to phantoms, 
where the ground truth is clearly defined by the phantom design and therefore well-known. 
For clinical images the following surrogates of truth can be used: i) a consensus of several 
physicians or expert-drawn contours and/or ii) histopathological measurements of lesions 
resected within a reasonably short timeframe after the image acquisition and for which 1115 
special precautions are taken as described below.  
Consensus of several physician-drawn contours  
If the clinical endpoint is selected as the decision basis in the absence of histopathology 
information, consensus of several physician-drawn contours is sometimes used as a 
surrogate of truth. When the segmentation contours can potentially be used in different 1120 
clinical applications, images contoured by several experts or physicians from different 
specializations (e.g., the study by Bayne et al.191 in which 2 radiologists, 2 radiation 
oncologists and 2 nuclear medicine physicians contoured 5 NSCLC patients), might reduce 
bias due to personal and specialty-based preferences at the price of a likely slightly higher 
inter-observer variability due to differences in training and habits. On the other hand, when 1125 
considering a specific clinical application, such an approach may be less accurate than using 
consensus of contours drawn by several specialists in this specific application. Indeed, 
contouring by physicians from only one specialty, e.g., radiation oncologists25, may provide 
more reliable estimates for an endpoint corresponding to the goals of this specific sub-
specialty (target volume definition in this case). 1130 
The use of the consensus based methods discussed at the end of Section 2.B.2.d, 
which can account for a set of manual contours, may be expected to reduce errors under 
certain assumptions about the operators, as differences in performance or training can be 
taken into account (e.g., within the STAPLE framework). 
 1135 
Histopathological validation of PET image segmentation  
This type of PET-AS validation can be carried out by using PET images of tumor 
specimens for which histopathological characterization is also available. In this case, PET-AS 
contours can be tested directly against the histopathology-derived contours. At present, 
these data serve as the most clinically relevant ground truth of tumor extent. However, there 1140 
are several sources of errors that limit the accuracy of this surrogate of truth for PET-AS 
validation: (i) variable amount of deformation of the surgical specimen after excision, (ii) time 
difference between the PET scan and the specimen excision, (iii) uncertainty associated with 
manual delineation (usually by a single observer) of the tumor boundaries in digitized 
histopathology and (iv) imperfect co-registration of histopathology slices and PET volumes. 1145 
While these errors can potentially limit the validity of the comparison, histopathological 
validation is an important part of thorough PET-AS evaluation. At present, there are several 
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datasets in which effort was made to minimize these errors165. Examples are: the lung tumor 
dataset from the MAASTRO (Maastricht Radiation Oncology) team with pathology-validated 
maximum diameters139, the tumor datasets used in the study from the Jefferson Medical 1150 
College (max. diameter)192, the HNSCC (Head and Neck Squamous Cell Carcinoma),151 the 
NSCLC56 full 3D volumes reconstruction datasets from the Université Catholique de Louvain 
studies and the lobectomy-based dataset from The Netherlands Cancer Institute (NKI)193. 
Despite the challenges with respect to the accuracy of the reference contours, these 
pathology-validated images provide an important test for PET-AS methods. This justifies the 1155 
need for further improvement of the current experimental approaches, as well as 
development of new techniques to improve the accuracy of histopathological validation165, 194, 
195
. 
 It is important to note that because histopathological validation of PET image 
segmentation is carried out for a particular tissue and tracer pair, it cannot be implied that the 1160 
results apply to alternative PET tracer/tissue combinations; hence, one should exercise care 
when using PET-AS algorithms to segment tracer/tissue pair images different from those for 
which they were validated. It should be noted that evaluating PET segmentation against 
anatomic or surgical delineation could be potentially misleading since biodistribution of a 
particular PET radiotracer may not conform to these structures. This is especially true for 1165 
non-FDG tracers such as hypoxia probes where the entire tumor volume is not expected to 
display uptake. 
IV.C.4. Blind study and updates  
 
In order to facilitate the training and validation of PET-AS algorithms, it would be 1170 
optimal to separate the images of the future standard into two groups: a) With ground truth 
given to the PET-AS developers for learning/training and b) Blind study (without ground truth) 
for testing. The rationale behind a) is that some algorithms, e.g., the learning algorithms may 
need to be trained, whereas b) will ensure more objective evaluation and validation. Simple 
geometrically shaped phantoms naturally fall in the first category, whereas clinical images 1175 
are a natural candidate for the second group. Simulated images, or complex shape 
experimental phantoms, can be distributed among the two. 
Since both experimental and numerical phantoms are currently in rapid development, it 
is important to make provisions for updating and expanding the set of images. The 
benchmark’s goal can be better reached if it can facilitate and encourage the sharing of new 1180 
acquired datasets by contributing users. As new data and PET-AS algorithms become 
available, the evaluation process can be organized so that the new, shared datasets become 
gradually included in the standard. For example, a rule may be considered according to 
which, a certain fraction of the images (e.g., ~ 60%) must have been used for evaluating at 
least ten algorithms. 1185 
IV.D. Figures of merit and evaluation criteria  
Choosing the best set of Figures of Merit (FOM) depends on the complexity of the 
segmentation problem as well as on the evaluated endpoint. For example, when using 
spheres in a standard compartmental phantom, shape modifications and volume translations 
are unlikely to be observed. In this case, simple volumetric differences may be enough. In 1190 
more realistic images, inaccuracies in shape or location are more likely and need to be 
detected with a more complex FOM. A statistical approach can further distinguish between 
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two types of errors with respect to assigning a voxel to a lesion or normal tissue: Type I -  
false positives and Type II - false negatives. The various FOMs are discussed in detail in 
Appendix IV. The FOMs listed in Table 4 were considered for use in the future standard. 1195 
Most of these FOMs have advantages and drawbacks, some of which are listed in 
Table 4. For example, optimizing sensitivity alone would favor methods that encompass and 
therefore overestimate the true volume. Similarly, optimizing positive predictive value alone 
would instead favor methods that underestimate the true volume. Other criteria are not strict 
enough (e.g., volume difference), computationally expensive (e.g., Hausdorff distance 196), or 1200 
unable to distinguish between the two error types (false positive and false negative, 
e.g., Jaccard and DSC). Therefore, we caution against using a single performance metric for 
segmentation evaluation and rather suggest reporting several FOMs such as the combination 
of sensitivity and positive predictive value, in order to convey complementary information.   
Table 4. A comparison of various volume/contour agreement measures and their sensitivities 1205 
to the properties of the segmented lesions. The important properties are whether they 
account for volume differences, shape discrepancies, false positive vs. false negative. The 
computational complexity is graded between easy (+) and complicated (+++), although none 
of the metrics are particularly slow to compute using modern toolkits and computers 
(Barycenter distance is the distance between the centers of mass of two sets).  1210 
 Evaluation criteria Location Size Shape Type I/II  Complexity 
Volume difference no yes no no + 
Barycenter distance yes no no no ++ 
Jaccard similarity 
coefficient 
yes yes yes no ++ 
Dice similarity coefficient 
(DSC) 
yes yes yes no ++ 
Hausdorff distance yes no yes no +++ 
Sensitivity + Positive 
Predictive Value (PPV) 
yes yes yes yes ++ 
 
Notice that the Type I/II error distinction in sensitivity and PPV requires the knowledge 
of which of the two volumes is the actual ground truth, whereas other measures treat both 
volumes in the same way. In the absence of a ground truth volume (neither A nor B is 
preferred), then the Dice similarity coefficient can be used instead of Sensitivity + PPV. 1215 
As discussed in section IV.B, some image datasets, e.g., simulated and experimental 
images, may have more accurately defined ground truth than others, (e.g., clinical images 
accompanied with pathological results or manual contours). In the case of a less accurately 
defined ground truth, the inverse-ROC approach, used by Shepherd, et al.115, can give a 
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reliable evaluation of the algorithms, provided a set of contours (e.g., manual delineations) 1220 
that encompass the ground truth contour exist. 
Due to the complexity of the PET segmentation problem, more appropriate evaluation 
metrics will need to be derived from investigations of correlations between the assessment of 
these metrics and a clinical endpoint. In the case of radiotherapy treatment planning, an 
example would be the geometrical concordance of the delivered dose distributions to the 1225 
PET segmentation contour and the treatment outcome. Tools which can account for such 
information have recently been proposed197. 
V. DISCUSSION OF SEGMENTATION LIMITATIONS, DEPENDENCIES 
AND IMPLEMENTATION 
V.A Biological limitations of the segmentation concept 1230 
It has long been realized that cancer is an abnormal growth caused by unregulated cell 
proliferation. Cancerous tissue morphology is highly irregular and characterized by chaotic 
vascularization, resulting in a unique pattern of blood flow for every tumor, which modifies 
PET tracer availability and uptake in a way unique for each patient. Also, different parts of the 
same tumor can have very different micro-environmental status, including different levels of 1235 
glucose metabolism. Other factors affecting intratumoral PET tracer distribution are the 
presence of necrosis and stromal tissue intertwined with cancer cells. As a result, the 
intratumoral pattern of FDG uptake is highly heterogeneous.  
While it is possible to carry out in vitro studies to relate PET tracer binding/uptake to 
environmental parameters of the cells in culture, direct in vivo application of such data is 1240 
highly speculative and lacks strong foundation due to the reasons listed above. The 
uniqueness and stochastic nature of the factors governing PET tracer uptake and its 
intratumoral distribution in each patient represents one of the biggest challenges for PET 
image segmentation. The complexity of the problem hampers the widespread adoption of 
auto-segmentation tools for routine clinical use. 1245 
Other factors can also potentially affect PET-based lesion segmentation. Tumors may 
lack a well-defined boundary separating them from the surrounding normal tissues. 
Microscopic cancer extensions can produce additional blurring of this idealized, macroscopic 
boundary. Furthermore, in addition to heterogeneities of tracer uptake in the lesion, 
surrounding normal structures are likely to be characterized by different levels of tracer 1250 
uptake. Inflammation, if present, can result in further complications by significantly increasing 
FDG uptake. Correspondingly, the biological meaning of the segmented volume should be 
interpreted in the context of all these biological factors governing image formation in PET. 
Therefore, both PET image segmentation as well as interpretation of the segmentation result 
are very non-trivial tasks and should be approached with caution. However, for situations 1255 
where tumor delineation is needed, e.g., radiation therapy treatment planning, the right 
choice of properly validated PET-AS methods used as a guidance tool by the physician can 
result in increased target definition accuracy and better treatment.   
 
V.B.  Dependence on segmentation task 1260 
 
There may be significant differences in terms of tumor segmentation algorithm 
parameterization and use, depending on the task. At the same time, it should be emphasized 
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that most published methods have been proposed either as a general PET segmentation 
approach, which can be used in any application (although rarely tested or validated for all), or 1265 
as a method developed and validated for a specific clinical application (e.g., radiotherapy 
planning, without being tested in another setting). 
In treatment planning the PET information can be used in two ways198:  
1. Target volume delineation: The PET-based GTV should safely encompass the entire 
tumor volume without missing regions with low radiotracer accumulation. In order to 1270 
avoid cancer under treatment, even equivocal voxels would usually be included. 
However, to avoid over irradiation of too large a volume of normal tissue, the GTV 
should not be larger than needed. To account for microscopic disease the radiation 
oncologist then draws the CTV by adding a margin to the GTV (section IV.A). 
Uncertainties to the tumor contour for external radiotherapy may be generated based on the 1275 
accuracy of the method as determined during the evaluation stage. The delineation 
uncertainty can be approximated as a shell or annular volume around the segmented 
volume. The thickness of the annular shell could, for example, be derived from the average 
thickness of the annular volume between the overlap and union volumes of the segmentation 
and reference surfaces determined during the evaluation stage. Other options are to use 1280 
distance metrics between these surfaces, which can be based on the Hausdorff distance or 
similar methods199. 
2. Target substructure determination: In contrast, PET-based definition of tumor sub-
volumes for so-called biologically conformal radiotherapy or dose painting2 requires a 
different approach. In dose painting, radiation is shaped according to the PET uptake, 1285 
theoretically delivering higher dose to the radiation resistant and/or tumor-rich parts of 
the tumor. In order to achieve this goal, one needs to rely on a detailed understanding 
of the underlying tumor biology and PET signal (e.g., PET tracer uptake and retention 
mechanisms), as well as how to determine the dose prescription function based on 
the PET signal. In that specific context, radiotracers different than FDG have been 1290 
investigated, e.g., use of FMISO-PET might indicate hypoxic regions  and the use of 
FLT-PET might indicate tumor proliferative regions where increased dose  is needed. 
In such cases PET-AS methods would need to be able to define both the entire tumor 
volume as well as sub-volumes with different levels of activity. In some rare cases, 
multi-tracer datasets can be available and the images combined to define a biological 1295 
target volume (BTV). Methods based on information fusion have been proposed to 
address this specific challenge170, 200-202. 
For treatment response assessment: 
1. Segmentation can be used for the estimation of various uptake measurements (mean 
SUV, total SUV, heterogeneity of uptake using, e.g., histogram-derived first order 1300 
features or more complex second and third order textural features), which may 
correlate better with the clinical outcome than less comprehensive metrics, such as 
maximum or peak SUV.   
2. Automatic segmentation can be used for more consistent longitudinal tracking of 
treatment response to various cancer therapies. Repeatability and reproducibility of 1305 
segmentation in this case could be more important than absolute accuracy, especially 
within the context of the known relatively high test-retest variability of PET scan 
imaging203, 204.  
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The PET avid volume and/or on tumor-to-background ratio may change as a result of 
therapy.  Therefore for PET-AS methods which are dependent on these parameters (e.g. 1310 
some adaptive threshold methods23, 52) use of the same method for segmentation of PET 
images before and after therapy without proper adjustment of parameters may result in 
incorrect and inconsistent segmentation. This may then affect the accuracy of the metrics 
derived from the segmented volume.  In general using FDG for adaptive radiation therapy 
may be problematic due to change of the SNR as a result from reduction of the tumor uptake 1315 
and/or inflammation. This means that, for example,  a threshold set to 42% of peak activity 
may provide erroneous results if the tumor/background ratio changes substantially or if the 
PET avid volume decreases under a certain value 48.  This volume was found to be about 1.5 
mL for older PET scanners but will be partial volume and therefore scanner dependent. 
Similarly, if the PET avid volume has an irregular shape with both wide and thin parts, the 1320 
threshold may have to be adapted to the effective size of these parts of the volume. 
 The time saved by using automatic segmentation is also important; lack of time in 
daily practice is one of the major limitations preventing investigators from using ROI-based 
methods for treatment response assessment in cases where volume (or volume-derived) 
information is important. As a result, in current practice, SUVmax and SUVpeak, which are less 1325 
dependent on accurate edge
 
and volume definition, are more widely used for response 
assessment. Automatic segmentation provides consistency and time efficiency in longitudinal 
studies. However, consistency is harder to achieve for PET measures dependent on the 
segmented volume (e.g., SUVmean, SUVtotal), compared to measures that do not depend on it, 
but simply follow the voxel(s) with highest activity concentration anywhere within the GTV 1330 
(e.g., SUVmax, SUVpeak).  
In addition, even for a single clinical goal (e.g., radiation treatment planning), the PET-
AS methods may meet different requirements for different disease types and body sites. This 
may profoundly affect the method evaluation process. For example, this may result in 
favoring relatively simple, e.g., adaptive threshold methods, optimized for each lesion type 1335 
versus more complex advanced methods, which may do equally well in different parts of the 
body. During the development of a future evaluation standard, this possibility may be 
investigated by sorting the performance results of the PET-AS methods between body sites 
and tumor types. 
 1340 
V.C. Dependence on scanner, image acquisition and reconstruction protocol 
One major consideration in PET image analysis is the lack of standardization of clinical 
imaging protocols resulting from hardware and software variability, as well as the variation of 
procedures between clinical centers (injected dose, delay between injection and acquisition, 
acquisition duration, etc.). Thus, every post-acquisition, post-reconstruction analysis and 1345 
extraction of relevant parameters from PET images depend on the actual qualitative and 
quantitative characteristics of the analyzed PET image (e.g., resolution and noise), which are 
strongly influenced by the acquisition protocol. For this reason users are cautioned to always 
evaluate and validate published PET-AS methods for their specific clinical application and 
scanning protocol before clinical use. 1350 
Recently, there have been several efforts to propose ways for the standardization of 
imaging procedures. These efforts have sought to minimize the impact of acquisition 
protocols on the resulting visual quality and quantitative accuracy and consistency of PET 
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images4, 205, 206 207. One of the main reasons is to help improve consistency in multi-center 
trials that combine images acquired from different clinical centers, scanners and imaging 1355 
protocols.  
These efforts are to be encouraged. By reducing the existing variability in PET images 
encountered in clinical practice, they will contribute toward improved data consistency, which 
will facilitate the use of PET-AS algorithms across different centers and thus allow the use of 
advanced quantitative tools for treatment assessment. This will also contribute to reducing 1360 
the dependence of PET defined tumor volumes on the specific instrumentation and protocols 
in a given clinical center.  
The quality of an image is defined by several parameters, which may have different 
importance for different tasks208-211.  Segmentation differs from typical diagnostic tasks in that 
it seeks to identify the boundary locations and therefore uses a much larger parameter 1365 
space. Based on this, there is an expectation that this problem is more ill-posed and requires 
less noisy data to reduce errors.   
This can be achieved by modifying the injected activity, uptake period, acquisition and 
image reconstruction. Increasing the injected activity may improve the noise equivalent count 
rate. Typically, the injected activity is unaltered from that used for diagnostic imaging and it is 1370 
possible that the risk from therapy is large enough that it outweighs the risks associated with 
injecting a larger amount of activity. For the case of FDG-PET, a 1-hour post-injection delay 
is used; however, the contrast ratio of uptake to background continues to increase with 
time. This 1 h selection is due to tradeoffs between workflow, consistency, diagnostic 
efficacy, etc. Increased dwell times over the tumor regions and/or additional spot scans can 1375 
also be used to improve the images. 
Increasing the number of counts in the data using these approaches would allow 
achieving higher resolution image by increasing the number of iterations while preserving the 
noise level212, 213. Beyond this, some penalized image reconstruction methods with edge 
preserving prior models have been developed214-218. These may produce images with edges 1380 
that are more easily segmented. These tradeoffs may be considered for future protocol 
optimizations together with the risks associated with higher doses related to therapy. 
 
V.D. Dependence on tracer type and physical isotope  
Current investigations are dominated by FDG and 18F-based tracers. This is 1385 
understandable because FDG remains the most widely used radiotracer in oncologic 
imaging. However, there is a growing interest in non-FDG tracers, including radiolabeled 
amino acids such as L-methyl-11C-methionine (MET) or O-(2-18F-fluoroethyl)-L-tyrosine (FET) 
for brain tumor delineation, proliferation markers such as 18F-3′-fluoro-3′-deoxy-L-thymidine 
(FLT) or hypoxia tracers such as 18F-fluoromisonidazole (F-MISO). At least some of these 1390 
agents show a lower intensity of uptake in tumor lesions than FDG (e.g., FLT and FMISO), 
and thus physicians may apply different criteria for what constitutes significant radiotracer 
uptake (for instance in comparison to background reference regions or blood activity). In fact, 
little attention has been given to the question of how the use of these alternate radiotracers 
can affect the accuracy of the various segmentation algorithms. Most of the segmentation 1395 
approaches have been designed for FDG-PET. Also most fixed and adaptive threshold-
based methods are optimized for a specific range of tumor-to-background ratios. However, 
some methods have been used successfully on different radiotracers219, 220. For some tracers 
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a lower target-to-background ratio may lead to significant problems in the use of threshold-
based algorithms.  Tracers other than FDG may be of great interest for dose painting and 1400 
contouring of tumor sub-volumes. However, for isotopes other than 18F, differing physical 
parameters, such as positron range and emission of cascade gamma rays, may degrade 
image quality and must be taken into account. This emphasizes the need for more robust 
algorithms that can deal with varying contrast and noise levels in reconstructed images. 
Histological validation of such tracer accumulation is necessary to determine sensitivity, 1405 
specificity and detection limits before these agents can be considered for dose modulation.  
It should be noted that multi-tracer datasets have been acquired in research protocols 
and clinical trials in order to investigate the complementary value of different tracers. Since 
the acquisition and investigation of multi-tracer data is currently in its dawn and their 
segmentation is a very specific and challenging task outside common clinical practice we are 1410 
limiting their discussion only to this paragraph. Several novel methods have been developed 
to segment such data, usually with the goal of deriving a single biological target volume 
(BTV) from multi-tracer images. The use of information fusion has been suggested to achieve 
this as early as 2011200-202  and some recent fusion-based methods have been evaluated with 
promising results170. 1415 
New, more sophisticated pattern recognition/machine learning algorithms are also on 
the horizon; these may make use of more subtle image characteristics, including noise 
distribution, underlying PSF, and nominal biological distribution. Such algorithms will require 
training sets of expert identified and segmented data and will only be valid for the type of 
data they were trained to process (see section II.B.2). Therefore, while at present most 1420 
segmentation schemes are radiotracer/isotope agnostic, this may rapidly change, as more 
sophisticated image-processing techniques become available. 
V.E. Effect of motion 
Motion can have an important impact on the apparent size, shape and contrast of 
lesions in PET images, especially in the thoracic area, due to respiratory motion. There has 1425 
been a significant advancement of respiratory motion correction algorithms based on breath 
hold, external or internal gating, deformation corrections and post-frame summing, blur 
deconvolution and others221-238. Of these the data driven gating approaches of PET images 
promise to yield comparable results with less discomfort for the patients and to be more 
efficient than hardware driven approaches239-241. The development of synergistic algorithms, 1430 
which account for motion simultaneously with segmentation, is also expected242-244.  
 
In the context of stereotactic body radiotherapy (SBRT) it has been shown that it may 
be useful to derive respiratory correlated target volumes from gated (4D) PET/CT scans in 
addition to 4D-CTs 243, 245, 246. However, the current common practice still is to segment the 1435 
PET volume integrated over the scan time. If PET-AS algorithms are evaluated on clinical 
images against the activity as seen in the uncorrected PET image, endpoint a) as described 
in section IV.A, the potential effect of breathing motion in these images is disregarded. If the 
CT images are also used in the segmentation process, the uncorrected PET images should 
not be used for cases potentially affected by motion due to possible misalignment between 1440 
the CT and PET. 
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V.F.  Guidelines for acceptance and implementation for PET auto-segmentation 
algorithms  
Vendors have adapted and further developed some of the PET-AS methods when 
implementing them in commercial software. However, the number of published algorithms is 1445 
much larger than the number of those implemented (see section II.B.5). The algorithms 
implemented by vendors, while being adaptations of published algorithms, may have 
modifications and enhancements that have a “black box” quality if vendors are reluctant to 
disclose proprietary techniques. Therefore, the vendors may have specific recommendations 
on how to test their PET-AS algorithms, which the user should address first.  1450 
An additional factor to consider is the variability in implementations in the various 
commercial software visualization and analysis platforms. As it has been recently 
demonstrated, even for very simple metrics such as SUVmax, considerable variability has 
been shown to exist across various vendors and software, likely due to implementation 
errors, as well as different interpretation of, or assumptions about the data247. The developed 1455 
digital reference object is a very useful tool that will allow verification and validation of the 
vendor’s implementation. Indeed, similar observations were made regarding contours and 
volumes that were substantially modified when transferred from one station to another248. It 
is, indeed, not uncommon to transfer segmentation results such as contours from one station 
to another (e.g., a nuclear medicine-dedicated analysis station to a radiotherapy planning 1460 
station) and the user should verify their consistency. In that respect, considerable 
standardization efforts are needed to ensure that adopted PET-AS methods will be correctly 
implemented and the results are compatible across the various platforms of different 
vendors.  
Following vendor suggested acceptance testing, this task group envisions a three   1465 
phase procedure (Table 5) for the implementation of segmentation algorithms that reflect the 
different level of closeness to reality of the PET images (see section IV). The images to be 
used in the three stages would contain lesions represented by; (1) spherical/cylindrical 
objects, (2) irregularly shaped objects and (3) human datasets. Since each of these image 
types may present a different evaluation endpoint (IV.A) and specific challenges that depend 1470 
on how it was generated, this will allow a more thorough evaluation of PET-AS methods.  
Most current implementation tests typically stop with the first phase, incorrectly 
assuming that the PET-AS algorithm would be sufficiently accurate for realistic clinical 
images. For the first phase, phantoms with spherical inserts (diameter: 1 cm – 4 cm) imaged 
at varying object-to-background ratios (e.g., 2:1 to 10:1) can be used. In addition, iodinated 1475 
contrast can be used to aid in segmenting the ground truth volumes and in excluding the wall 
of the objects in the CT images. Simple shape (e.g., spherical) objects in uniform 
background, preferably without cold wall,171, 172, 174 are also most convenient for robustness 
evaluation across scanners and reconstruction schemes.  
For the second phase, a combination of physical phantoms capable of constructing 1480 
irregularly shaped objects115, 174 and non-uniform activity distributions178, as well as 
numerically simulated phantoms that contain irregular shaped objects and/or non-uniform 
uptake, can be selected among the family of phantoms discussed in IV.C.1 and IV.C.2. 
Finally, for the third phase for which we suggest using clinical images, the main limitation is 
insufficient knowledge of the ground truth. As discussed in IV.C.3, ground truth surrogates 1485 
such as pathology findings of excised specimens and/or statistical consensus from several 
manually drawn contours (preferably by different experts) can be used. Since both ground 
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truth surrogates have a fair degree of uncertainty, the benchmark dataset should ideally 
comprise both of these image types.  
The evaluation metrics for assessment of the segmentation accuracy are described in 1490 
IV.D. While several of these tools can be used, a combined metric, e.g., including sensitivity, 
positive predictive value and Hausdorff distance is expected to provide a more reliable 
method assessment (see. IV.D.3). However, further investigations are needed to generate a 
combined evaluation metric that is not affected by biases of the metrics or correlations 
between them. We suggest that the results of the evaluation stage be used to estimate the 1495 
contouring uncertainty as discussed in section V.B. 
A standard, which will provide access to the selected benchmark datasets and various 
performance metrics, is currently under construction by members of the task group 168, 249, 250. 
As pointed out in the last column of Table 5, the ultimate evaluation of segmentation will be 
analyzing the outcome of treatments using the respective segmentation approach. 1500 
Table. 5 Stages of evaluation of PET auto-segmentation (PET-AS) methods. DSC (Dice 
Similarity Coefficient), PPV (Positive Predictive Values), HD (Hausdorff Distance). 
Step 1. Vendor 
acceptance 
2. Basic 
evaluation 
3.  Phase two 
evaluation:  
4. Phase three 
evaluation 
5. Impact 
evaluation 
Objective Proper 
functioning 
of software 
Accuracy of 
clinic-specific 
images; 
robustness of 
image 
properties 
Accuracy, 
repeatability and 
robustness of 
realistic shapes and 
variable uptake;  
Accuracy, 
repeatability and 
robustness of 
clinical images 
from the intended 
application 
Evaluation of 
clinical impact 
Datasets Vendor 
recommen
dation 
Simple 
objects in 
uniform 
background; 
repeated 
acquisitions 
Irregular shape 
and/or non-uniform 
uptake lesions in 
experimental or 
digital  phantoms 
without cold wall; 
multiple realizations 
Clinical images Clinical images, 
treatment plans 
and follow-up 
records 
Ground 
truth 
Vendor 
recommen
dation 
CT defined 
voxel level 
accuracy. 
High resolution CT 
or digital ground-
truth defined voxel 
level accuracy. 
Digitized 
histopathology 
and/or consensus 
of several manual 
delineations 
 Treatment 
outcome data 
Metrics Vendor 
recommen
dation 
Volume 
errors, DSC 
DSC, Sensitivity, 
PPV, HD 
DSC, Sensitivity, 
PPV, HD, 
Statistical 
evaluation of 
clinical endpoint 
(prognostic/predicti
ve value)  
Statistical multi-
parameter 
treatment 
outcome analysis 
 
Ideally, a segmentation algorithm would be portable across different scanners with their 
individual and sometimes proprietary reconstruction schemes and parameters. Since this 1505 
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may not always be realistic for many PET-AS algorithms, the implementation should be 
appropriately tagged as being optimized for specific scanner types and protocols. 
The minimum requirements for an algorithm depend on the intended application goal: 
diagnostic, therapy planning, or treatment/prognostic assessment. For diagnosis, the most 
important aspect of the PET-AS method is its ability to identify the tumor (not necessarily 1510 
exact extents/boundaries) for a large range of tumor sizes on either original or PVE corrected 
images, in order to provide the most accurate volume and the associated activity.  
For radiotherapy planning, the minimum requirements include the PET-AS’s accuracy 
in the delineation of the gross tumor volume and the ability to identify sub-volumes (for dose 
boosting/painting/redistribution applications), as is its ability to achieve a high sensitivity (to 1515 
be sure to include the entire target) with minimal loss of specificity (to reduce irradiation of 
healthy tissues and organs at risk).  
In the case of response assessment, the main requirement is that the portion of the 
tumor image that maximizes the predictive power of the particular parameter (biomarker) 
used, is correctly segmented. As a result, for this type of segmentation task, the link to the 1520 
physical aspects of the tumor and imaging system are difficult to convincingly establish, and 
the need for the clinical impact evaluation step (Step 4, Table 5) is especially important251. 
Also in most cases, for follow-up and therapy assessment applications, the PET-AS 
algorithm will have to be applied to serial scans independently, although developments 
dedicated to consider simultaneously sequential scans are also being developed200, 201, 252-255. 1525 
Therefore, its robustness versus different contrast, heterogeneity and tumor size is extremely 
important in order to provide non-biased results regarding the evolution of tumors during 
therapy. AAPM Task Group 174 (Utilization of 18F-Fluorodeoxyglucose Positron Emission 
Tomography (FDG-PET) in Radiation Therapy) is working towards standardizing the 
methodology used for sequential scanning (or even inter-patient scanning for clinical trial 1530 
patients), so as to allow segmentation techniques to be used for fair comparison between the 
pre- and intra/post-treatment PET scans. 
Type of disease and body site dependence of the performance of PET-AS methods 
should also be expected. This means that the user should evaluate the chosen PET-AS 
algorithm for the intended body site. Furthermore, within the context of multi-centric studies, it 1535 
is important that the chosen algorithm be validated for robustness against the varying noise 
and texture properties associated with different scanner models and reconstruction 
algorithms and their associated parameters (voxel sizes, etc.). Alternatively, the algorithm 
should be easy to adapt/optimize to the characteristics of each individual center/scanner. 
Scanning the same phantom at the involved institutions and comparing PET-AS method 1540 
performance is suggested. The limitations of the selected phantom need to be well-
understood as discussed in IV.C. 
V.G.  The complementary role of manual and auto-segmentation for PET  
In order to satisfy the requirements laid out in the previous sections, PET-AS algorithms 
need to accurately account for the physical and technical sources of bias and uncertainty in 1545 
the PET images. In addition, the ideal PET-AS algorithm should be able to account for 
anatomical, physiological and other clinical information not present in a PET image, which 
can alter the location of a contour. Although some of the algorithms listed in Table 1 promise 
to answer most of the physical requirements, accounting for clinical information not present in 
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the PET image is beyond the capabilities of most available PET-AS algorithms. As a result, 1550 
there is a need for active physician involvement in the segmentation process. Therefore, at 
present and in the near future, automatically generated contours can be used only as a 
starting point for GTV delineation by the physician, who may decide to change them based 
on his/her knowledge. It is likely that human supervision will remain necessary, both before 
and after the process of automatic contouring, although this rule may change in the future256. 1555 
A recent work has presented a method for head-and-neck, in which user interaction is kept 
minimal but exploited nonetheless so that the user can provide simple cues to guide the 
segmentation algorithm in an efficient and intuitive manner 257. 
Before auto-contouring:  
Because automatic contouring algorithms cannot distinguish between malignant and 1560 
benign tissue tracer uptake, the selection of the lesion, i.e., the diagnostic decision to regard 
a certain region of elevated tracer uptake as malignant, must be done by a knowledgeable 
physician. This step includes all forms of diagnostic decision making, considering clinical 
information not present in the image, topography, pattern and anatomical location of the 
suspected uptake, as well as the probability for malignant spread.  1565 
After auto-contouring:  
The review and editing of the final contour is required for consistency with known 
diagnostic information, including findings by other imaging modalities, endoscopy results and 
clinical knowledge. The contours drawn on the same lesion may differ if the goal is 
therapeutic (need to include all malignant tissue) compared to the case when the goal is 1570 
diagnostic (need to mark structures containing tumor with a high probability).  
To ensure a smooth workflow in daily practice, the contouring software should facilitate 
both automatic contouring and user interactions for lesion selection and contour editing or 
algorithm guidance (by providing better initialization, for example258). It is also necessary to 
enable co-viewing or fusing of the PET scan with other imaging modalities to include all 1575 
diagnostic information in the contouring process. In this context, beyond the application of 
well-designed and thoroughly evaluated algorithms for automatic contouring, the use of multi-
modality imaging and collaboration between radiation oncologists and/or oncologists, and 
imaging specialists (e.g., diagnostic radiologist and/or nuclear medicine expert) are 
necessary to ensure better understanding of planning images.  1580 
VI. CONCLUSIONS 
Given the large number of published PET-AS algorithms, their different level of 
validation and because most of these published algorithms are not yet implemented in 
commercially available software, recommending a single PET-AS method is challenging and 
premature. Furthermore, even if such a recommendation could be made it may become 1585 
obsolete considering the rapid development of the field. Instead, we have provided basis for 
understanding the logic and the limitations of the main classes of approaches and a 
framework for their rigorous evaluation and comparison, which we believe will be of greater 
value for future developments. 
As reviewed in this report, there is accumulating evidence in the literature pointing to 1590 
the higher accuracy and robustness of the approaches based on more advanced image 
segmentation and analysis paradigms, when supplemented with manual and visual 
verification, compared to simple threshold-based approaches. These advantages, however, 
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come at the expense of the ease of implementation and understanding of the simpler 
algorithms. At the same time it is possible that simpler (e.g., adaptive threshold) methods 1595 
may perform comparably well, if not better, for a certain body site/disease type if specifically 
optimized for these conditions. Recent algorithms which employ some type of consensus or 
automatic selection between several PET-AS methods have a potential to overcome the 
limitations of the individual methods when appropriately trained. In either case, accuracy 
evaluation is required for each different PET scanner and scanning and image reconstruction 1600 
protocol. For the simpler, less robust approaches, adaptation to scanning conditions, tumor 
type and tumor location by optimization of parameters is necessary. The results from the 
method evaluation stage can be used to estimate the contouring uncertainty. All PET-AS 
contours should be critically verified by a physician.  
Clearly, further research for solving the dilemma of PET image segmentation is 1605 
needed, and one potential solution for going forward is the creation of a standardized 
protocol (i.e., a benchmark) for consistent evaluation and comparison of the PET-AS 
methods. This task group suggests the following considerations for generating such a 
standard: 
1) The evaluation endpoints need to be clearly separated based on algorithmic 1610 
accuracy and clinical relevance. In order of increasing clinical relevance the 
reference choices are:  a) the unmodified PET images; b) the tracer distribution 
corrected for artifacts; c) the underlying histopathology. 
2)  At present, the benchmark needs to consist of several image datasets of different 
types: experimental (phantoms), numerically simulated and clinical, in order to 1615 
compensate for the deficiencies of each of them. Also, a complete set of images 
should include images from all body sites, since algorithm performance may depend 
on local tracer uptake specifics.  
3)  The performance of the methods needs to be evaluated using different metrics, 
which include volume overlap measures, classification evaluation tools as well as 1620 
voxel-to-voxel distance metrics. 
 
These considerations are the core of the guidelines for PET-AS algorithm evaluation 
presented in more details in section V.F. 
 1625 
A standard that conforms to these requirements will provide a more objective 
comparison of the algorithms by mitigating the large variability of image sets and metrics 
used for evaluation. At present, a benchmark following these recommendations is under 
development within the task group. Different PET-AS methods are currently being tested 
within this framework to evaluate the benchmark design and components168, 249,250. A publicly 1630 
available tool such as this should aid users in evaluating current algorithms to increase 
confidence in selecting the most adequate PET-AS method to use for a particular application 
under physician supervision and to provide reference criteria to evaluate future methods.  
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Appendix I 
PET-AS Formalism examples 
 1645 
A) Fixed and Adaptive Threshold algorithms  
 
Thresholding could be expressed as follows: ܫ⏞ ∈ Υ�ሺܫ௜ሻ = {ͳ,Ͳ, ܫ௜ ≥ ܶ,ܫ௜ < ܶ, ܫ௜ ∈ ܫ�ை�    (A1) 
where  Υ�ሺ∙ሻ is the indicator function for threshold T, I⏞ is the segmented subset of the voxels 1650 
within a Volume of Interest (VOI) in image I, and Ii is the uptake value (generally normalized 
to SUV) at voxel �. 
 
The particular thresholds for performing segmentation are often found by minimizing the 
difference between known volumes, Vk୬୭୵୬, (typically a phantom study) and the volumes 1655 
defined by applying different thresholds,  VሺTሻ. This often is described as, ܶ∗ = argmin�(�௞௡௢௪௡ − �ሺܶሻ)ଶ     (A2) 
which could be solved by a least-squares estimation technique. Additionally, it is possible to 
add some topological constraints to I⏞ to ensure its connectedness and/or that it is simply 
connected, to avoid islands or holes within the segmentation ROI. In case of NSCLC the 1660 
optimal threshold for a specific scanner and protocol46 was related to volume via, ܶሺ�ሻ = ܫ௠௔௫ ቀ5ͻ logଵ଴ � ቀܫ⏞ቁ − ͳͺቁ ,    ܫ௜ ∈ ܫ⏞   (A3) 
where  I୫ୟ୶ is the maximum uptake in the segmented subset and  V ቀ I⏞ቁ is the segmented 
volume. The functional forms of various threshold segmentation schemes are given in Table 
A 1. 1665 
 
Table A1: Functional forms of various threshold segmentation schemes. 
Comments Threshold Estimator 
Drever, et al.’s single-parameter FTS fit259: It is most 
notable for its use of the histogram’s mode for more stable 
estimation of the background. 
 ܶ = ܽ(ܫ௠௔௫ − ܫ௕௞௚) + ܫ௕௞௚ 
Nestle, et al.’s single-parameter FTS fit23: This fit uses the 
mean of voxels greater than 70% of the lesion’s maximum. 
The use of the mean instead of the maximum uptake 
reduces the variability. 
 
 ܶ = ܽ ܫ௠௘௔௡,7଴%௠௔௫ + ܫ௕௞௚ 
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Daisne, et al.’s show a two-parameter FTS fit model 149: 
The scaling parameter, I୫ୟ୶, can be recast as a mean-
value or volume-based measure for an ATS algorithm260. 
ܶ = ܽ + ܾ ܫ௕௞௚ܫ௠௔௫ 
Schaefer, et al.’s two-parameter FTS fit30: This fit is 
extended from Nestle’s scheme above23.   ܶ = ܽ ܫ௠௘௔௡,7଴%௠௔௫ + ܾ ܫ௕௞௚ܫ௠௔௫  
Erdi, et al.’s two-parameter FTS fit48: uses a fixed 
threshold of 42%. It was noted that it worked well for large 
lung tumors, however the authors go on to say that its use 
should be limited to homogeneous uptake distributions. 
 ܶ = ܽ ݁−௕ �ሺ�ሻ 
 
Black, et al.’s two-parameter ATS fit53: The use of the 
mean SUV to make the algorithm more stable to noise 
requires a threshold for its calculation. 
ܶ = ܽ + ܾ ܫ௠௘௔௡(�ሺܶሻ) 
 
Biehl, et al.’s two-parameter ATS fit46: The volume is the 
GTV defined by CT. This algorithm is shown to work for a 
wide range of tumor volumes in NSCLC.  
ܶ = ܫ௠௔௫(ܽ + ܾ ݈�ሺܥܶீ ��ሻ) 
Jentzen, et al.’s three-parameter ATS fit51: The parameters 
were fitted from phantom data. The inverse volume 
requires a threshold. 
ܶ = ܽ�ሺܶሻ + ܾ ܫ௕௞௚ܫ௠௔௫ + ܿ 
 
Nehmeh, et al.’s four-parameter ATS fit52: The fit used 
Monte Carlo simulation results to avoid cold wall effects. 
ܶ = ܫ௠௔௫ (ܽ + ܾ �௖ሺܶሻ݁ௗ �ሺ�ሻ⁄ ) 
 
Burger, et al.’s Background Subtracted Lesion (BSL) 261:  
Not meant as segmentation but rather a volume estimation 
scheme, an equivalent volume threshold can be found (Li 
et al.262) Note that this method tends to overestimate the 
volume by including spill-out. 
Procedure: ܶ, such that the volume from a 
threshold matches the volume 
used in the BSL measurement. 
 
B) Segmentation of multimodality imaging: 
In the case of Fuzzy C-Means (FCM) multimodality segmentation, a fuzzy membership 1670 
function and the cluster center ܿ௞௡ are updated according to �௜௞௡ = ‖௫�−௖��‖∑ ‖௫�−௖��‖−మ��=భ , ܿ௞௡+ଵ = ∑ (���� )�௫���=భ∑ (���� )���=భ    (A4) 
where �௜௞௡  is the fuzzy membership probability that image pixel �௜ belongs to cluster ݇ at 
iteration �, and ܿ௞௡ is the updated cluster center intensity. 
In the case of Multi Valued Level Sets (MVLS), the objective functional for N imaging 1675 
modalities could be presented as: infୡ ܬሺܥ, ܿ+, ܿ−ሻ ∝ ଵே ∑ ቀ  �௠+ ∫ |ܫ௠ሺ�ሻ − ܿ௠+ |ଶܪ(�ሺ�ሻ) ݀�Ω + �௠− ∫ |ܫ௠ሺ�ሻ − ܿ௠− |ଶ ቀͳ − ܪ(�ሺ�ሻ)ቁ ݀�Ω ቁ ௠ , 
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           (A5) 
where ܫ௠ሺ�ሻ  is the intensity from imaging modality m  at image location x, � is the level set 
function. ܿ௠+ ሺܿ௠− ሻ corresponds to the pixel intensity mean values inside (outside) of the 1680 
contour Cm.  ܪሺ∙ሻ is the Heaviside function and ሺ�௠+ , �௠− ሻ are user-defined parameter pairs 
providing relative importance weights for each of the imaging modalities m. The target 
boundary is defined at the zero level ሺ�ሺܥሻ = Ͳሻ and the integrals are over the space  of 
each image type. 
 1685 
Appendix II. Uptake Normalization and Threshold Parameter Estimation 
Uptake normalization: 
Preprocessing the uptake data is important for inter-patient comparisons and for 
defining a segmentation scheme. The most common uptake preprocessing is the conversion 
to SUV. The use of it or something similar is essential to making the selection of a threshold 1690 
activity independent and applicable across patients and institutions47. SUV itself comes in 
many flavors, with normalization being carried out with respect to total body mass, lean body 
mass, body surface area, etc. Beyond SUV, it has been advocated normalizing patient data 
to the aortic arch (RTOG 1106)263, 264 or to mean liver uptake. For inter-patient comparisons 
these normalizations are likely sufficient, but for segmentation, the tumors themselves may 1695 
need additional and individual normalization. 
For segmentation, further normalizing the intensity within the images or VOI allows for 
greater consistency between different image sets. Although several segmentation algorithms 
based on contour detection or region determination through contrast measurements do not 
require nor benefit from any SUV conversion, such SUV normalization is often used for 1700 
segmentation. Many algorithms23, 30, 53, 259, 260, 265 rely on subtracting the background activity 
from the images. In such cases the segmentation effectively uses a function of this form: �௜ = �(ܫ௜ , ܫ௕௞௚, ܫ�௘௙) = ( ��−���೒)( ��೐೑−���೒)  ,   (A6) 
where Irୣ୤ is a reference voxel value and Iୠk୥ is the background value, often Irୣ୤ = I୫ୟ୶.  As a 
further simplification, the image can be normalized solely to Irୣ୤ under the assumption that 1705 Iୠk୥ is small and does not vary much between images. The maximum contrast results in ξ୫ୟ୶ = ͳ and all voxels for which ξi ≥ T within the VOI are included in the segmented volume. 
While alternatives to the equation above exist, the various values that compose it are often 
similar. As a result, some discussion regarding their choice is useful. 
In choosing the voxel values used to define the equation above, some care is 1710 
necessary to ensure that they are relatively insensitive to the segmentation region and image 
noise266. In the case of the background value, Iୠk୥ is often taken to be the mean intensity 
over a large region, where the mean is taken from voxels that are far enough from the edge 
of the object to avoid PVE. Alternatively, when using a histogram approach the mode (the 
most frequent value) of the voxels’ intensity distribution can be chosen instead of the 1715 
mean265, 267. The mode has the advantage of being less susceptible to PVE near the edge of 
the lesion. In either case, both the mean and the mode are typically well-defined and 
relatively insensitive to image noise. 
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On the other hand, for the reference uptake value, Irୣ୤, the choice of the maximum 
intensity voxel in the object tends to be sensitive to the image noise thus using I୫ୟ୶ is 1720 
problematic23, 30, 53, 260. Virtually all phantom-based threshold models assume that the activity 
is uniform in the lesion. Yet the maximum intensity voxel of a region is very sensitive to the 
size of the object; large objects may exhibit a larger variation of their maximum SUV than 
small ones. In patient data, this is less clear due to tumor heterogeneity, but it has prompted 
the use of alternative definitions to maximum SUV for characterizing tumor uptake, such as 1725 
peak SUV, a grouping of the 10 highest uptake voxels, or similar268. One approach described 
in Nestle, et al.23 and later expanded on by Schaefer, et al.30 is to define the reference value 
as the mean of a region defined by a percent threshold of the maximum voxel (in both papers 
70% max SUV). This approach helps reduce the noise associated with a single voxel and 
provides some stability to the measurement. Using the mean of the segmented volume 1730 
makes the threshold a function of the segmentation boundary and requires an iterative 
solution. 
 
APPENDIX III.  PET Phantoms 
Table A2. A summary of the existing phantoms that are considered as potential candidates to 1735 
provide data for a future PET-AS evaluation protocol. 
Name or type 
and Reference 
Example figure and brief description Advantages Disadvantages 
Experimental phantoms 
IEC,  NEMA 
NU 2-2001173 
 
Known 
ground truth, 
Variable 
sphere size, 
Widely 
available 
Overly simple 
unrealistic 
lesion shapes; 
Uniform 
background; 
cold walls 
“Porous 
phantom,” 
Di Filippo, et 
al. 2004172 
 
Fig. T.A2.2. Perforated discs used for the 
construction of the hot spheres: multi 
resolution (left), multi contrast (right). 
Reprinted with permission from Med. 
Phys. J.. 
Adds variable 
contrast, 
eliminates 
cold walls 
Simple shapes, 
Uniform uptake 
Tedious 
manufacturing 
Fig. T.A2.1. Image 
of a transaxial slice 
through the center 
of the spheres 
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“Swiss 
cheese,”  
Hunt, et al. 
2007171  
 
Similar to the 
“Porous 
phantom,” 
above 
Easier 
manufacturing 
Simple shapes, 
Uniform uptake 
 
Tumor 
phantom, 
Shepherd, et 
al. 2012115 
 
Fig. T.A2.4. PET images and CT image 
based iso-surface of the tumor model 
phantom. 
Irregular 
shapes 
including 
branching 
Based on 
clinical 
images 
Ground truth 
in PET image 
space from 
hybrid CT 
thresholding 
Cold walls of 
glass 
compartments 
 
Does not 
recreate 
heterogeneity 
(requires 
internal medium 
of spatially 
varying 
absorbance)  
Molecular 
sieves, 
Zito, et al. 
2012174 
 
Known 
ground truth; 
irregular 
shapes 
Uniform lesion 
uptake; uniform 
background 
Fig. T.A2.5. 
CT and PET 
images of 3 
zeolites with 
superimposed 
ground truths. 
Fig. T.A2.3. A cut 
view of the 
phantom, 
produced by 
rapid prototyping. 
Reprinted with 
permission from 
Med. Phys. J.. 
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Using 
Radioactive 
Ink in 2D and 
3D printers, 
Larsson, et al. 
2000175, El-Ali, 
et al. 2003176, 
Miller & 
Hutchins, 
2008269,177, 
Berthon et al, 
2015270 
 
 
Fig. T.A2.6. PET image of the human 
brain phantom produced by incorporating 
a radioactive dye in rapid prototyping.269 
(Reprinted with permission.) 
Can match 
the irregular 
shape and 
non-uniform 
uptake of real 
lesions 
A specially 
adapted and 
calibrated 
printer is 
needed 
NonU 
phantom, 
Kirov, et al. 
2011178 
 
Fig. T.A2.7. 
Can match 
the irregular 
shape and 
non-uniform 
uptake of real 
lesions and 
background. 
Expensive 
Need  to 
improve 
accuracy of 
ground truth  
Simulated phantoms 
Simulated PET 
images from 
forward 
projected 
reference 
images, 2015 
181
 
 
 
Fig. T.A2.8. A schematic showing the 
generation of PET-like images from 
reference activity, tumor and attenuation 
distribution images. These reference 
images are forward projected, scaled, 
blurred and noise is added to simulate 
realistic PET data that is subsequently 
reconstructed.  
Realistic 
tumor and 
normal 
tissues and 
organs 
simulations, 
irregular 
shapes and 
heterogen-
eous activity 
distributions 
Known 
ground truth 
Because 
geometric 
projection, rather 
than photon 
transport is 
used, many of 
the physical 
aspects of the 
real image 
acquisition 
process are 
ignored 
Monte Carlo 
simulations 
Le Maitre, et 
al. 2009 271 
 
Realistic 
tumor and 
normal 
tissues and 
organs 
simulations, 
Computationally 
expensive; 
requires 
extensive up 
front experience. 
Relative activity levels 
of the reference 
activity distribution 
obtained by displacing 
activity by thin foils 
with irregular cutouts.  
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Papadimitro-
ulas, et al. 
2013 272 
 
Fig. T.A2.9. 
irregular 
shapes and 
heteroge-
neous 
activity 
distributions; 
Known 
ground truth 
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APPENDIX IV: Evaluation Criteria for Segmentation Tools 
 1740 
Agreement between sets of voxels 
Let A and B be two volumes lying in space S composed of voxels. This space can be 
the 3D image matrix or the field of view of a scanner. Volumes A and B are subsets of this 
space. A and B are therefore sets of voxels. 
The measured volume of A is equal to v|A|, where v is the voxel size expressed in 1745 
volume units and |A| denotes the cardinality of A. The voxel size does not need to be 
specified and the volume of A can be expressed by its cardinality without loss of generality. 
The agreement between A and B basically depends on the cardinality of their 
intersection |ܣځܤ| . The disagreement is reflected by the two set differences |ܣ\ܤ| and |ܤ\ܣ|, i.e., elements of A that are not elements of B and vice versa, respectively. There are 1750 
therefore two types of errors. These are also absolute errors. The simplest normalization 
factor is |A∪B|−1. In this case, we have  |஺ځ஻||஺ڂ஻| + |஺\஻||஺ڂ஻| + |஻\஺||஺ڂ஻| = ͳ   (A8) 
The first term is known as the Jaccard similarity coefficient, which varies between 0 and 1. 
For example, let us assume that A and B are different volumes but |ܣ| = |ܤ| and |ܣځܤ| =1755 |ܣ| ʹ⁄ . Given this then we have |ܣڂܤ| = ͵/ʹ|ܣ| and the Jaccard coefficient is equal to 1/3, 
whereas the overlap actually represents 50% of A. This distortion of the intuitive perception 
of the overlap is addressed by the Dice Similarity Coefficient (DSC), which is defined as  Diceሺܣ, ܤሻ = ଶ|஺ځ஻||஺|+|஻|.   (A9) 
The normalization factor is the inverse of the average volume. In the same example as 1760 
above, the DSC is equal to 1/2 and concurs with the intuition. It can easily be verified that the 
DSC varies between 0 and 1.  
At this point, both A and B have been considered on the same footing. Let us now 
define A as representing some ground truth and that B is defined as an observation of A with 
some inaccuracies. In this case, |ܣ\ܤ| and |ܤ\ܣ|are the numbers of false negatives (FN) and 1765 
false positives (FP), respectively. This, and the above information, can be written in a 
confusion matrix as [|ܣځܤ| |ܣ\ܤ||ܤ\ܣ| |ܵ\ሺܣڂܤሻ|] ,   (A10) 
where |ܵ\ሺܣڂܤሻ| is the number of true negatives (TN), which is obviously of little interest, as 
it depends primarily on the unimportant volume of space S, contrary to true positives (TP) in 1770 |ܣځܤ|. The most natural normalization factor here is |A|. The ratio |ܣځܤ|/|ܣ| is closely 
related to the DSC, provided we have |ܤ| = |ܣ|. We have here a single equality given by |஺ځ஻||஺| + |஺\஻||஺| = |஺||஺| = ͳ   (A11) 
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because  |஺ځ஻||஺| + |஻\஺||஺| = |஻||஺|   (A12) 1775 
can obviously be larger than 1 as soon as |ܤ| > |ܣ|. This issue can be addressed by using 
the specificity and sensitivity, defined by  spec. = |�ே||�ே|+|ி௉|   and  sens. = |�௉||�௉|+|ிே| .  (A13) 
Because the number of true negatives depends on the space volume, the specificity makes 
little sense and only the sensitivity conveys useful information. The specificity can be 1780 
replaced with the positive predictive value (PPV) (see Fig.A1 for visual illustration of 
sensitivity and PPV), defined as  
   PPV = |஺∩஻||஻| = |�௉||�௉|+|ி௉| .    (A14) 
 
 
 1785 
Fig. A1. A graphical illustration of the Jaccard and the Dice similarity coefficients, and of the 
sensitivity and the positive predictive value (PPV). 
All quantities described above assume that set operations can be computed. If only the 
cardinalities |ܣ|and |ܤ| are known, then only the volume difference |ܣ| − |ܤ|can be found. 
The normalization factor can be either |ܣ| or ሺ|ܣ| + |ܤ|ሻ ʹ⁄ . The volume difference has two 1790 
critical shortcomings. First, there is no possibility of distinguishing Type I and Type II errors, 
apart from the difference sign. Second, the volume difference is overly optimistic: it can be 
optimal ሺ|ܣ| − |ܤ| = Ͳሻ with actually no overlap (|ܣ| = |ܤ| but |ܣ ∩ ܤ| = Ͳ). The overlap can 
be approximated with the distance between the centroids (or barycenters) of A and B, for 
instance. 1795 
Hausdorff distance 
If set A is rewritten as {ܽ௜} and set B as { ௝ܾ}, then �(ܽ௜ , ௝ܾ) can denote the distance 
between voxels ܽ௜ and ௝ܾ. This distance can be the Euclidean distance from the center of ܽ௜ 
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to the center of ௝ܾ. Starting from this voxel-to-voxel distance, the Hausdorff distance is 
defined as 273: 1800 HDሺܣ, ܤሻ = max{max௜ min௝ �(ܽ௜, ௝ܾ) , max௝ min௜ �(ܽ௜, ௝ܾ)} . (A15) 
The first term calculates the maximum of the distances from each element of A to the closest 
element of B. The second term performs the symmetric computation, with respect to B 
instead of A. The maximum of these two quantities is the Hausdorff distance and they can be 
considered separately to extract information about errors of Types I and II. 1805 
The main shortcoming of the Hausdorff distance is its (relative) computational 
complexity. Notice also that the maximum and minimum operators involved in the definition 
are very sensitive to image noise. A straightforward variant of the Hausdorff distances 
addresses this issue by replacing the max operators with averages. This leads to a modified 
Hausdorff distance 274: 1810 MHDሺܣ, ܤሻ = ଵ|஺| ∑ min௝ �(ܽ௜, ௝ܾ)௜ + ଵ|஻| ∑ min௜ �(ܽ௜, ௝ܾ)௝  . (A16) 
The Hausdorff distance is good at reflecting translations between A and B, as well as shape 
discrepancies. Its interpretation, in terms of volumetric changes, is less obvious. In that 
sense, it is complementary to the volume difference and to overlap indexes. 
The Hausdorff distance can be computed on contours and surfaces as well, instead of 1815 
sets of voxels. However, in this case the implementation is more specific and requires the 
user to make some specific choices and/or to adjust additional parameters. 
It can be noted that all quantities described above depend on the image matrix or voxel 
grid. The finer the grid is, the closer the estimated quantities will be to their actual value. 
 1820 
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TABLES 
Table 1. Summary of the main characteristics of some representative advanced PET-AS 2705 
algorithms (not an exhaustive list) and their respective evaluation. 
Reference(s) 
Image 
segmentation 
paradigm(s) used 
User 
interaction 1 
Pre- and post-
processing steps 
Aimed 
application2 
Validation data 
and ground truth 
3
 
Accuracy 
evaluation 
on realistic 
tumors5 
Robustness 
evaluation6 
Repeatability 
evaluation 
Tylski, et al. 
2006 62  Watershed 
Std + multiple 
markers 
placement 
None Global PA(1): Vol. and CiTu images No No No 
Werner-
Wasik, et al. 
2012 63 
Gradient-based 
Std  + 
initialization 
using drawn 
diameters 
Unknown Global PA(5): Diam. 31 MCST: Vol. Yes Yes Yes 
Geets, et al. 
200737 Gradient-based 
Std  + 
initialization 
Denoising and 
deconvolution 
steps 
Global 
PS(1) and PA(1): 
Vol. + Diam. 
7 CiTuH: 
Complete 
No No No 
El Naqa, et al. 
200864 
 
AT + active 
contours 
Std + several 
parameters to 
set 
None Global PA(1): Vol. 1 CiTu - Ø Yes No Yes 
El Naqa, et al. 
200731 
Multi-modal 
(PET/CT) active 
contours 
Std  + 
initialization of 
the contour 
shape, selection 
of weights 
Normalization and 
registering of PET 
and CT images, 
deconvolution of 
PET images. 
GTV definition 
on  PET/CT 
PA(1): Vol. 
2 CiTu: MC(1), FT Yes No No 
Dewalle-
Vignion, et al. 
201165 
Possibility theory 
applied to MIP 
projections 
Std  None  Global 
PA(1): Vol. 
5 MCST: Vox. 
7 CiTuH: 
Complete 
Yes No No 
Belhassen 
and Zaidi 
201028 
Improved Fuzzy C-
Means (FCM) 
A posteriori 
interpretation of 
resulting classes 
in the 
segmentation of 
entire image 
Denoising, wavelet 
decompositions Global 
3 AST: Vox. 
21 CiTuH: Diam. 
7 CiTuH: 
Complete 
Yes No No 
Aristophanous
, et al. 200766 
Gaussian mixture 
modeling without 
spatial constraints 
Std  + 
initialization of 
the model and 
selection of the 
number of 
classes 
None Pulmonary tumors 7 CiTu: Ø No No Yes 
Montgomery, 
et al. 200767 
Multi scale Markov 
field segmentation 
A posteriori 
interpretation of 
resulting 
segmentation on 
the entire image 
Wavelet 
decompositions Global 
PA(1) : Vol. 
3 CiTu: Ø No No No 
Hatt, et al. 
200768 
Fuzzy Hidden 
Markov Chains Std  None Global 
PS(1) and PA(2): 
Vox. No No No 
Hatt, et al. 
200969, 2010 
70
,201143 
Fuzzy locally 
adaptive Bayesian Std None Global 
PS(1) and PA(4): 
Vox. 
20 MCST: Vox. 
18 CiTuH: Diam. 
 Yes Yes Yes 
Day, et al. 
200960 
Region growing 
based on mean 
and SD of the 
region 
Std + 
optimization on 
each scanner 
None  Rectal tumors 18 CiTu: MC(1) No No No 
Yu, et al. 
200940, 
Markel, et al. 
201371 
Decision tree built 
based on learning 
of PET and CT 
textural features 
A posteriori 
interpretation of 
resulting 
segmentation on 
the entire image 
Learning for 
building  the 
decision tree 
GTV definition 
of H&N and 
lung tumors 
10 CiTu: MC(3) 
31 CiTu: MC(3) No No No 
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Sharif, et al. 
201072, 201273 Neural network 
A posteriori 
interpretation of 
resulting 
segmentation on 
the entire image. 
Learning for 
building the neural 
network 
Global 
PA(1): Vol. 
3 AST: Vox. 
1 CiTuH: Diam. 
No No Yes 
Sebastian, et 
al. 200674 
Spherical Mean 
shift Std  
Resampling in a 
different spatial 
domain 
Global 280 AST: Vox. No No No 
Janssen, et 
al. 200975 
Voxels 
classification based 
on time-activity 
curve 
Std  + 
Initialization and 
choice of the 
number of 
classes 
Only on dynamic 
imaging, denoising 
and deconvolution 
steps 
Rectal tumors 
in dynamic 
imaging 
PA(1): Vol. + 
Diam. 
21 CiTu: MC(1) 
No No No 
De Bernardi, 
et al. 201076 
Combined with 
PVE (image 
reconstruction) 
Std + 
initialization 
PSF model of the 
scanner and 
access to raw data  
required 
Global PA(1): Vol. No Yes No 
Bagci, et al. 
201333 
Multimodal random 
walk Std 
Multimodal images 
registration 
Global for 
PET/CT or 
PET/MR 
77 CiTu: MC(3) 
PA(1) Yes No No 
Onoma, et al. 
2014 77 
Improved random 
walk Std None Global PA(1), 4 AST: 
Vox, 14 CiTu: 
MC(2) 
Yes No No 
Song, et al. 
201332 
Markov field + 
graph cut Std None Global 3 CiTu: MC(3) Yes No No 
Hofheinz, et 
al. 201361 
Locally adaptive 
thresholding 
Std + one 
parameter to 
determine on 
phantom 
acquisitions 
None Global 30 AST: Vox. Yes No No 
Abdoli, et al. 
201378 Active contour 
Std + several 
parameters to 
optimize 
Wavelet 
decompositions Global 
1 AST: Vox. 
9 CiTuH: 
Complete. 
3 CiTuH: 
Complete 
2 CiTuH: 
Complete 
No Yes No 
Mu, et al. 
2015 79 
Level set combined 
with PET/CT Fuzzy 
C-Means 
Std None Specific to 
cervix 
7 AST: Vox, 27 
CiTu: MC(2) Yes No No 
Cui, et al. 
2015 80 
Graph cut 
improved with 
topology modeling 
Std + one free 
parameter 
previously 
optimized 
PET/CT 
registration 
Specific to lung 
tumors and 
PET/CT 
20 PA(1), 40 
CiTu(2) Yes No No 
Lapuyade-
Lahorgue, et 
al. 2015 81 
Generalized fuzzy 
C-means with 
automated norm 
estimation 
Std None Global 
PA(4): Vol. 
34 MCST: Vox. 
9 CiTu: MC(3). Yes Yes Yes 
This	article	is	protected	by	copyright.	All	rights	reserved
Au
th
or
 M
an
us
cr
ip
t
 78 
 
Devic et al, 
2016 82  
Differential uptake 
volume histograms 
for identifying 
biological target 
sub-volumes 
Selection of 
three ROIs 
encompassing  
PET avid area; 
iterative 
decomposition 
of differential 
uptake 
histograms into 
multiple 
Gaussian 
functions 
None 
Isolation of 
glucose 
phenotype 
driven 
biological sub-
volumes 
specific to 
NSCLC,  
None No No No 
Berthon et al, 
2016 83 
Decision tree 
based learning 
using nine different 
segmentation 
approaches (region 
growing, 
thresholds, FCM, 
etc.) with the goal 
of selecting the 
most appropriate 
method given the 
image 
characteristics 
Std 
Learning on 100 
simulated cases to 
train/build the 
decision tree 
Global 85 NSTuP: Vox. 
 
Yes No No 
Schaefer et 
al, 2016 84 
Consensus 
between contours 
from 3 
segmentation 
methods (contrast-
oriented, possibility 
theory, adaptive 
thresholding) 
based on majority 
vote or  STAPLE 
Std None Global 
22 CiTuH; 
Complete 
10 CiTu: MC(4) 
10 CiTu: MC(1) 
Yes No Yes 
 
Table legend 
1
 std = « standard » interaction (i.e. the metabolic volume of interest is first manually isolated in a 
region of interest that is used as an input to the algorithm.) 2710 
2
 global = not application specific 
3
 PA(x) = Phantom (spheres) Acquisitions on x different scanners; PS(x) = Phantom (spheres) 
Simulations on x different scanners; AST = Analytically Simulated Tumors; MCST = Monte Carlo 
Simulated Tumors; NSTuP = Non spherical tumors simulated in phantoms (thin-wall inserts, printed 
phantoms, etc.). CiTu = Clinical Tumors; CiTuH = Clinical Tumors with Histopathology 2715 
Vol. = only volume; Vox. = voxel-by-voxel; Diam = histopathology maximum diameter; Complete = 3D 
histopathology reconstruction; MC(x) = manual contouring by x experts; FT = fixed threshold, AT = 
adaptive threshold 
4
 Highly heterogeneous, complex shapes, low contrasts and rigorous ground truth. 
5
 Requires multiple acquisitions on different systems and a large number of parameters. 2720 
6 With respect to different scanners and protocols 
 
Table 2. A summary of segmentation method comparisons and  reviews.  
No. Reference Compared 
methods 
Images or 
Phantoms 
used 
Results and/or 
recommendations 
reported by the 
authors 
Limitations and 
comments by 
TG211 or others 
as cited 
Comparison studies 
1 Nestle, et Visual Patient scans Large differences Only visual 
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al. 200523 segmentation, 
40% of 
SUVmax 
threshold, 
SUV>2.5 
threshold, and 
an adaptive 
threshold 
between volumes 
obtained with the 4 
approaches 
segmentation 
used as a 
surrogate of truth 
and only clinical 
data. 
2 Schinagl, 
et al. 
2007158 
Visual 
segmentation, 
40% and 50% 
of SUVmax 
threshold, and 
adaptive 
thresholding 
78 Clinical 
PET/CT 
images of 
head and neck 
The 5 methods led 
to very different 
volumes and shapes 
of the GTV. Fixed 
threshold at SUV of 
2.5 led to the most 
disappointing 
results. 
The GTV was 
defined manually 
on CT and used 
as a surrogate of 
truth for PET-
derived delineation 
and only clinical 
data was used. 
3 Geets, et 
al. 200737, 
Wanet, et 
al. 201156 
Fixed and 
adaptive 
thresholding, 
gradient-
based 
segmentation 
Phantom 
(spheres), 
simulated 
images, clinical 
images of lung 
and H&N 
cancers with 
histopathology 
3D 
measurements 
More accurate 
segmentation with 
gradient-based 
approach compared 
to threshold 
Numerous issues 
associated with 
the 3D 
reconstruction of 
the surgical 
specimen used as 
gold standard. 
4 Greco, et 
al. 2008159 
Manual 
segmentation, 
50% SUVmax, 
SUV>2.5 
threshold and 
iterative 
thresholding 
12 Head and 
neck cancer 
patients.  
Thresholding PET-
AS algorithms are 
strongly threshold-
dependent and may 
reduce target 
volumes significantly 
when compared to 
visual and 
physician- 
determined 
volumes.  
 
Limitations: 
reference GTVs 
defined manually 
on CT and MRI.  
5 Vees, et al. 
2009160 
Manual 
segmentation, 
SUV>2.5 
threshold, 
40% and 50% 
of SUVmax 
threshold, 
adaptive 
thresholding, 
gradient-
based method 
18 Patients 
with high grade 
glioma  
PET often detected 
tumors that are not 
visible on MRI and 
added substantial 
tumor extension 
outside the GTV 
defined by MRI in 
33% of cases. 
The 2.5 SUV 
isocontour and 
“Gradient Find” 
Ground-truth 
derived from 
manual 
segmentation on 
MRI only. 
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and region 
growing. 
“segmentation 
techniques 
performed poorly 
and should not be 
used for GTV 
delineation”. 
 
6 Belhassen, 
et al. 
2009161 
Three 
different 
implement-
ations of the 
fuzzy C-
means (FCM) 
clustering 
algorithm 
Patient scans Incorporating 
wavelet transform 
and spatial 
information through 
nonlinear anisotropic 
diffusion filter 
improved accuracy 
for heterogeneous 
cases  
No comparison 
with other 
standard methods 
7 Tylski, et 
al. 201042 
Four different 
threshold 
methods (% 
of max activity 
and three 
adaptive 
thresholding), 
and a model-
based 
thresholding 
Spheres in an 
antropomor-
phic torso 
phantom as 
well as non 
spherical 
simulated 
tumors 
Large differences 
between volumes 
obtained with 
different 
segmentation 
algorithms. Model-
based or 
background-
adjusted algorithms 
performed better 
than fixed 
thresholds. 
No clinical data, 
limited to 
threshold-based 
algorithms only, 
only volume error 
considered as a 
metric 
8 Hatt, et al. 
201070, 
201143, 152 
Fixed and 
adaptive 
thresholding, 
Fuzzy C-
means, FLAB 
IEC phantom 
(spheres); 
simulated 
images, clinical 
images with 
maximum 
diameter 
measurements 
in 
histopathology 
Advanced 
algorithms are more 
accurate compared 
to threshold- based 
and are also more 
robust and 
repeatable. 
For clinical 
images, only 
maximum 
diameters along 
one axis were 
available from 
histology. 
9 Dewalle-
Vignion, et 
al. 201165, 
2012162 
Manual 
segmentation, 
42% of 
SUVmax, 2 
different 
adaptive 
thresholding, 
fuzzy c-mean 
and an 
advanced 
method based 
on fuzzy set 
Phantom 
images, 
simulated 
images, clinical 
images with 
manual 
delineations 
The advanced 
algorithm is more 
accurate and robust 
than threshold-
based and closer to 
manual delineations 
by clinicians 
Only manual 
delineation for 
surrogate of truth 
of clinical data.  
Comments: 
Interesting use of 
various metrics for 
assessment of 
image 
segmentation 
accuracy. 
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theory.  
10 Werner-
Wasik, et 
al. 201263  
Manual 
segmentation, 
fixed 
thresholds at 
25% to 50% 
of SUVmax (by 
5% 
increments) 
and gradient-
based 
segmentation 
IEC phantom 
(spheres) in 
multiple 
scanners, 
simulated 
images of lung 
tumors 
A gradient-based 
algorithm is more 
“accurate and 
consistent” than   
manual and 
threshold 
segmentation.  
Only volume error 
used as a metric 
of performance. 
“…manual 
verification using 
CT scan should be 
performed (…)  
GTV definition 
requires joint 
assessment by the 
radiologist, nuclear 
physician and 
radiation 
oncologist” 163 
11 Zaidi, et al. 
2012150 
Five 
thresholding 
methods, 
Standard and 
improved 
fuzzy c-
means, level 
set technique, 
stochastic 
EM. 
Patient scans 
with 
histopathology 
3D 
measurements 
(same as #5 
above) N/A 
The automated 
Fuzzy c-means 
algorithm provided 
was shown to be 
more accurate than 
5 thresholding 
algorithms, the level 
set technique, the 
stochastic EM 
approach and 
regular FCM. 
Adaptive threshold 
techniques need to 
be calibrated for 
each PET scanner 
and acquisition/pro-
cessing protocol and 
should not be used 
without optimization.  
Numerous issues 
associated with 
the 3D 
reconstruction of 
the surgical 
specimen used as 
gold standard. See 
Table 1 
12 Shepherd, 
et al. 2012 
115
 
30 methods 
from 13 
different 
groups. 
Tumor and 
lymph-node 
metastases in 
H&N cancer 
and physical 
phantom 
(irregular 
shapes). 
Simulated, 
experimental 
and clinical 
studies 
Highest accuracy is 
obtained from 
optimal balance 
between interactivity 
and automation. 
Improvements are 
seen from visual 
guidance by PET 
gradient as well as 
by using CT.  
Limitation: a small 
number of objects 
(n=7) were used 
for the evaluation. 
13 Schaefer, 
et al. 
2012157 
 
One adaptive 
thresholding 
Phantoms, 
same 
threshold 
The calibration of an 
adaptive threshold 
PET-AS algorithm is 
Confirmation of 
previous findings 
about adaptive 
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technique algorithm, 
different 
scanners  
scanner and image 
analysis software- 
dependent.  
threshold 
segmentation.  
14 Schinagl et 
al. 2013 164 
Visual, SUV 
of 2.5, fixed 
threshold of 
40% and 
50%, and two 
adaptive 
threshold 
based 
methods 
using either 
the primary or 
the 
metastasis  
Evaluation of 
the segmen-
tation of 
metastatic 
lymph nodes 
against 
pathology in 12 
head and neck 
cancer patients  
SUV of 2.5 was 
unsatisfactory in 
35% of cases; for 
the last four 
methods: i) using 
the node as a 
reference gave 
results comparable 
to visual 
ii) using the primary 
as a reference gave 
poor results;  
Shows the 
limitations of 
threshold based 
methods.  
15 Hofheinz, 
et al. 2013, 
61
 
Voxel-specific 
adaptive 
thresholding  
and standard 
lesion-specific 
adaptive 
threshold  
30 simulated 
images based 
on real clinical 
datasets. 
The  voxel-specific 
adaptive threshold 
method was more 
accurate than the 
lesion-specific one 
in heterogeneous 
cases 
 
Only simulated 
data were used. 
16 Lapuyade-
Lahorgue, 
et al. 2015 
81
 
Improved 
generalized 
fuzzy c-
means, fuzzy 
local 
information C-
means and 
FLAB  
34 simulated 
tumors and 9 
clinical images 
with 
consensus of 
manual 
delineations. 3 
acquisitions of 
phantoms for 
robustness of 
evaluation.  
In both simulated 
and clinical images, 
the improved 
generalized FCM led 
to better results than 
another FCM 
implementation and 
FLAB, especially on 
complex and 
heterogeneous 
tumours, without any 
loss of robustness 
on data acquired in 
different scanners. 
Only 9 clinical 
images used. 
 
Reviews 
1 Boudraa, 
et al. 2006 
39
 
N/A Mostly clinical 
images  
Extensive review of 
the fomalism of 
image segmentation 
algorithms used in 
nuclear medicine (not 
specific to PET and 
clinical oncology) 
Only a few 
algorithms have 
been rigorously 
validated for 
accuracy, 
repeatability and 
robustness. 
2 Lee, 
201029 
N/A Simulated, 
mostly clinical 
Discussed the main 
caveats of threshold- 
Extensive review 
of nuclear 
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 images based techniques 
including the effect of 
phantom cold walls 
on threshold. A 
discussion of the 
available and 
desirable validation 
datasets and 
approaches is also 
included.  
medicine image 
segmentation 
algorithms (not 
specific to PET 
and clinical 
oncology) 
3 Zaidi and 
El Naqa, 
2010 54 
 
N/AN/A Simulated, 
experimental 
and clinical 
studies  
Despite being 
promising, advanced 
PET-AS algorithms 
are not used in the 
clinic.  
 
4 Hatt, et al. 
201123 
N/A  N/A Only a few algorithms 
have been rigorously 
validated for 
accuracy, 
repeatability and 
robustness. 
See the three last 
columns of Table 
1 
5 Kirov A.S, 
Fanchon, 
L, 2014,165 
 
N/A  Clinical 
images with 
pathology 
derived 
ground truth.  
Articles comparing 
PET-AS methods are 
summarized 
separately for lesions 
in five groups based 
on location in the 
body with a focus on 
the accuracy, 
usefulness and the 
role of the pathology-
validated PET image 
sets.  
 
6 Foster, et 
al. 201436  
N/A  N/A  “although there is no 
PET image 
segmentation method 
that is optimal for all 
applications or can 
compensate for all of 
the difficulties 
inherent to PET 
images, development 
of trending image 
segmentation 
techniques which 
combine anatomical 
information and 
metabolic activities in 
the same hybrid 
Most exhaustive 
review of the 
state-of-the-art in 
2014. Uses a 
similar 
classification of 
methods as in the 
present report. 
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frameworks (PET-
CT, PET-CT, and 
MRI-PET-CT) is 
encouraging and 
open to further 
investigations.”  
 
 2725 
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Table 3.  Advantages and disadvantages of the different methods used for generation of test 
images. 
 
Experimental images Simulated images 
Simple 
Phantoms 
Realistic 
phantoms 
Clinical 
images 
Forward 
Projected 
Images 
Monte Carlo 
(MC) 
Simulations 
Advantages:  Exact 
representation 
of the scanner 
resolution, 
image noise 
and other 
image artifacts  Ground truth 
accurately 
known  Easy to 
generate and 
use 
 Exact 
representation of 
the scanner 
resolution, 
image noise and 
other image 
artifacts  Capable to 
produce  lesion 
shapes 
corresponding to 
actual tumors  Known ground 
truth 
 Exact 
representation of 
the scanner 
resolution, image 
noise and other 
image artifacts  Real tumors 
 
 Precise experimental 
control  Flexibility in phantom 
design  Precise knowledge of 
the reference object  Computationally 
cheap 
 Precise experimental 
control   Realistic count 
distributions  Flexibility in phantom 
design  Precise knowledge of 
the reference object  Camera-specific 
information 
Dis-
advantages: 
 The objects 
have simplistic 
and unrealistic 
shape and 
activity 
distribution  Most with few 
exceptions171, 
172
 have cold 
walls 
 
 Some 
uncertainties in 
the experiment 
can be hard to 
quantify  Difficult to 
generate 
inhomogeneous 
activity  Labor intensive 
 Uncertainties in 
the knowledge of 
the reference 
object, even with 
histopathology 
reference  
 
 Scatter count 
distributions and 
noise are usually less 
accurately modeled  Detailed physics and 
system information 
ignored 
 Computationally 
expensive  Model requires 
extensive up front 
experience 
 2730 
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Table 4. A comparison of various volume/contour agreement measures and their sensitivities 
to the properties of the segmented lesions. The important properties are whether they 2735 
account for volume differences, shape discrepancies, false positive vs. false negative. The 
computational complexity is graded between easy (+) and complicated (+++), although none 
of the metrics are particularly slow to compute using modern toolkits and computers 
(Barycenter distance is the distance between the centers of mass of two sets).  
 Evaluation criteria Location Size Shape Type I/II  Complexity 
Volume difference no yes no no + 
Barycenter distance yes no no no ++ 
Jaccard similarity 
coefficient 
yes yes yes no ++ 
Dice similarity coefficient 
(DSC) 
yes yes yes no ++ 
Hausdorff distance yes no yes no +++ 
Sensitivity + Positive 
Predictive Value (PPV) 
yes yes yes yes ++ 
 2740 
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Table. 5 Stages of evaluation of PET auto-segmentation (PET-AS) methods. DSC 
(Dice Similarity Coefficient), PPV (Positive Predictive Values), HD (Hausdorff Distance). 2745 
Step 1. Vendor 
acceptance 
2. Basic 
evaluation 
3.  Phase two 
evaluation:  
4. Phase three 
evaluation 
5. Impact 
evaluation 
Objective Proper 
functioning 
of software 
Accuracy of 
clinic-specific 
images; 
robustness of 
image 
properties 
Accuracy, 
repeatability and 
robustness of 
realistic shapes and 
variable uptake;  
Accuracy, 
repeatability and 
robustness of 
clinical images 
from the intended 
application 
Evaluation of 
clinical impact 
Datasets Vendor 
recommen
dation 
Simple 
objects in 
uniform 
background; 
repeated 
acquisitions 
Irregular shape 
and/or non-uniform 
uptake lesions in 
experimental or 
digital  phantoms 
without cold wall; 
multiple realizations 
Clinical images Clinical images, 
treatment plans 
and follow-up 
records 
Ground 
truth 
Vendor 
recommen
dation 
CT defined 
voxel level 
accuracy. 
High resolution CT 
or digital ground-
truth defined voxel 
level accuracy. 
Digitized 
histopathology 
and/or consensus 
of several manual 
delineations 
 Treatment 
outcome data 
Metrics Vendor 
recommen
dation 
Volume 
errors, DSC 
DSC, Sensitivity, 
PPV, HD 
DSC, Sensitivity, 
PPV, HD, 
Statistical 
evaluation of 
clinical endpoint 
(prognostic/predicti
ve value)  
Statistical multi-
parameter 
treatment 
outcome analysis 
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Table A1: Functional forms of various threshold segmentation schemes. 
Comments Threshold Estimator 
Drever, et al.’s single-parameter FTS fit259: It is most 
notable for its use of the histogram’s mode for more stable 
estimation of the background. 
 ܶ = ܽ(ܫ௠௔௫ − ܫ௕௞௚) + ܫ௕௞௚ 
Nestle, et al.’s single-parameter FTS fit23: This fit uses the 
mean of voxels greater than 70% of the lesion’s maximum. 
The use of the mean instead of the maximum uptake 
reduces the variability. 
 
 ܶ = ܽ ܫ௠௘௔௡,7଴%௠௔௫ + ܫ௕௞௚ 
Daisne, et al.’s show a two-parameter FTS fit model 149: 
The scaling parameter, I୫ୟ୶, can be recast as a mean-
value or volume-based measure for an ATS algorithm260. 
ܶ = ܽ + ܾ ܫ௕௞௚ܫ௠௔௫ 
Schaefer, et al.’s two-parameter FTS fit30: This fit is 
extended from Nestle’s scheme above23.   ܶ = ܽ ܫ௠௘௔௡,7଴%௠௔௫ + ܾ ܫ௕௞௚ܫ௠௔௫  
Erdi, et al.’s two-parameter FTS fit48: uses a fixed 
threshold of 42%. It was noted that it worked well for large 
lung tumors, however the authors go on to say that its use 
should be limited to homogeneous uptake distributions. 
 ܶ = ܽ ݁−௕ �ሺ�ሻ 
 
Black, et al.’s two-parameter ATS fit53: The use of the 
mean SUV to make the algorithm more stable to noise 
requires a threshold for its calculation. 
ܶ = ܽ + ܾ ܫ௠௘௔௡(�ሺܶሻ) 
 
Biehl, et al.’s two-parameter ATS fit46: The volume is the 
GTV defined by CT. This algorithm is shown to work for a 
wide range of tumor volumes in NSCLC.  
ܶ = ܫ௠௔௫(ܽ + ܾ ݈�ሺܥܶீ ��ሻ) 
Jentzen, et al.’s three-parameter ATS fit51: The parameters 
were fitted from phantom data. The inverse volume 
requires a threshold. 
ܶ = ܽ�ሺܶሻ + ܾ ܫ௕௞௚ܫ௠௔௫ + ܿ 
 
Nehmeh, et al.’s four-parameter ATS fit52: The fit used 
Monte Carlo simulation results to avoid cold wall effects. 
ܶ = ܫ௠௔௫ (ܽ + ܾ �௖ሺܶሻ݁ௗ �ሺ�ሻ⁄ ) 
 
Burger, et al.’s Background Subtracted Lesion (BSL) 261:  
Not meant as segmentation but rather a volume estimation 
scheme, an equivalent volume threshold can be found (Li 
et al.262) Note that this method tends to overestimate the 
volume by including spill-out. 
Procedure: ܶ, such that the volume from a 
threshold matches the volume 
used in the BSL measurement. 
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Table A2. A summary of the existing phantoms that are considered as potential candidates 
to provide data for a future PET-AS evaluation protocol. 
Name or type 
and Reference 
Example figure and brief description Advantages Disadvantages 
Experimental phantoms 
IEC,  NEMA 
NU 2-2001173 
 
Known 
ground truth, 
Variable 
sphere size, 
Widely 
available 
Overly simple 
unrealistic 
lesion shapes; 
Uniform 
background; 
cold walls 
“Porous 
phantom,” 
Di Filippo, et 
al. 2004172 
 
Fig. T.A2.2. Perforated discs used for the 
construction of the hot spheres: multi 
resolution (left), multi contrast (right). 
Reprinted with permission from Med. 
Phys. J.. 
Adds variable 
contrast, 
eliminates 
cold walls 
Simple shapes, 
Uniform uptake 
Tedious 
manufacturing 
“Swiss 
cheese,”  
Hunt, et al. 
2007171  
 
Similar to the 
“Porous 
phantom,” 
above 
Easier 
manufacturing 
Simple shapes, 
Uniform uptake 
 
Tumor 
phantom, 
Shepherd, et 
al. 2012115 
 
Fig. T.A2.4. PET images and CT image 
based iso-surface of the tumor model 
phantom. 
Irregular 
shapes 
including 
branching 
Based on 
clinical 
images 
Ground truth 
in PET image 
space from 
hybrid CT 
thresholding 
Cold walls of 
glass 
compartments 
 
Does not 
recreate 
heterogeneity 
(requires 
internal medium 
of spatially 
varying 
absorbance)  
Fig. T.A2.1. Image 
of a transaxial slice 
through the center 
of the spheres 
Fig. T.A2.3. A cut 
view of the 
phantom, 
produced by 
rapid prototyping. 
Reprinted with 
permission from 
Med. Phys. J.. 
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Molecular 
sieves, 
Zito, et al. 
2012174 
 
Known 
ground truth; 
irregular 
shapes 
Uniform lesion 
uptake; uniform 
background 
Using 
Radioactive 
Ink in 2D and 
3D printers, 
Larsson, et al. 
2000175, El-Ali, 
et al. 2003176, 
Miller & 
Hutchins, 
2008269,177, 
Berthon et al, 
2015270 
 
 
Fig. T.A2.6. PET image of the human 
brain phantom produced by incorporating 
a radioactive dye in rapid prototyping.269 
(Reprinted with permission.) 
Can match 
the irregular 
shape and 
non-uniform 
uptake of real 
lesions 
A specially 
adapted and 
calibrated 
printer is 
needed 
NonU 
phantom, 
Kirov, et al. 
2011178 
 
Fig. T.A2.7. 
Can match 
the irregular 
shape and 
non-uniform 
uptake of real 
lesions and 
background. 
Expensive 
Need  to 
improve 
accuracy of 
ground truth  
Simulated phantoms 
Simulated PET 
images from 
forward 
projected 
reference 
images, 2015 
181
 
 
 
Fig. T.A2.8. A schematic showing the 
generation of PET-like images from 
reference activity, tumor and attenuation 
distribution images. These reference 
images are forward projected, scaled, 
Realistic 
tumor and 
normal 
tissues and 
organs 
simulations, 
irregular 
shapes and 
heterogen-
eous activity 
distributions 
Known 
ground truth 
Because 
geometric 
projection, rather 
than photon 
transport is 
used, many of 
the physical 
aspects of the 
real image 
acquisition 
process are 
ignored 
Fig. T.A2.5. 
CT and PET 
images of 3 
zeolites with 
superimposed 
ground truths. 
Relative activity levels 
of the reference 
activity distribution 
obtained by displacing 
activity by thin foils 
with irregular cutouts.  
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blurred and noise is added to simulate 
realistic PET data that is subsequently 
reconstructed.  
Monte Carlo 
simulations 
Le Maitre, et 
al. 2009 271 
Papadimitro-
ulas, et al. 
2013 272 
 
 
Fig. T.A2.9. 
Realistic 
tumor and 
normal 
tissues and 
organs 
simulations, 
irregular 
shapes and 
heteroge-
neous 
activity 
distributions; 
Known 
ground truth 
Computationally 
expensive; 
requires 
extensive up 
front experience. 
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